2018 Annual Meeting | P1 - Poster Session I

Date Sunday 04/22/18

Time 11:30 AM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Research Methodology, ��ɫ��, and History, Sleep

CME Available 0.00 credit

Event Timeline
11:30 AM - 05:30 PM	Abstract	001 - Development and Preliminary Results of a Community-Partnered Stroke Preparedness Intervention in Chicago Neelum T. Aggarwal, MD
11:30 AM - 05:30 PM	Abstract	002 - Headache and Arts Program: Headache and Concussion ��ɫ�� in High School Visual Arts Classes Alexandra Boubour
11:30 AM - 05:30 PM	Abstract	003 - Readability assessment of online Essential Tremor patient educational resources
11:30 AM - 05:30 PM	Abstract	004 - Professional Art Therapy and Visuospatial Exploration in Parkinson's Disease: an Experimental Protocol and Preliminary Feasibility Data. Alberto Cucca, MD
11:30 AM - 05:30 PM	Abstract	005 - Youth Stroke ��ɫ�� Series Lucy Fell
11:30 AM - 05:30 PM	Abstract	006 - Internet Search Behavior Trends for Public ��ɫ�� in Neurology Field Saeed Ansari, MD
11:30 AM - 05:30 PM	Abstract	007 - Clinics as classrooms: assessing patient knowledge and satisfaction following stroke video education Sarah M. Tisel, MD
11:30 AM - 05:30 PM	Abstract	008 - Analysis of Early Post-Training Research Activity: The Effect of the Critical Years on Later Success of Physician-Scientists Wyatt P. Bensken
11:30 AM - 05:30 PM	Abstract	009 - Improving Confidence in Nurses When Performing a Neurological Assessment Scott M. Le, DO
11:30 AM - 05:30 PM	Abstract	010 - Teaching Psychiatrists Neurology through E-Learning: A Model Curriculum Nuri Jacoby, MD, FAAN
11:30 AM - 05:30 PM	Abstract	011 - Understanding Resident Workflow and ��ɫ��al Experience to Implement Advanced Practice Clinicians Into Neurology Residency Training Programs Laura K. Stein, MD, MPH
11:30 AM - 05:30 PM	Abstract	012 - A Pilot Neurology Curriculum To Train Advanced Practice Clinicians Joining An Inpatient Stroke Service At A Busy Tertiary Care Center Anna Pace, MD
11:30 AM - 05:30 PM	Abstract	013 - Developing a Comprehensive Pre-Residency Acclimatizing Program for International Medical Graduates Raghav Govindarajan, MD, FAAN
11:30 AM - 05:30 PM	Abstract	014 - Impact on ��ɫ�� and Quality of Care of a Neurology Free Clinic in Bogota, Colombia Jaime Toro, MD, FAAN
11:30 AM - 05:30 PM	Abstract	015 - Integrative Medicine in Child Neurology: what do providers think and what do they need to learn? Amanda Sandoval Karamian, MD
11:30 AM - 05:30 PM	Abstract	016 - Improving Resident Knowledge of Healthcare Business and Policy through the Development of a High-yield and Dynamic ��ɫ��al Series John Legge, MD
11:30 AM - 05:30 PM	Abstract	017 - Autism Spectrum Disorder (ASD) knowledge variation and gaps in adult neurology residents Surabhi Kaul, MD
11:30 AM - 05:30 PM	Abstract	018 - Knowledge of Genetics and Genetic Testing In an Academic Neurology Setting Sami Bajwa, MD
11:30 AM - 05:30 PM	Abstract	019 - Targeted Needs Assessment for a Competency-Based "Boot Camp" Curriculum for First-Year Neurology Residents Seraj O. Makkawi, MBBS, FRCPC, FAAN
11:30 AM - 05:30 PM	Abstract	020 - A single institutional study of neurology residents to evaluate the advantages of neuro-oncology didactics during training and understand field-specific attitudes Aubree Bruhnding, DO
11:30 AM - 05:30 PM	Abstract	021 - Awakening European Neurology - Sleep ��ɫ�� in Neurology (SEN) survey Martin Rakusa, MD
11:30 AM - 05:30 PM	Abstract	022 - NA
11:30 AM - 05:30 PM	Abstract	023 - NA
11:30 AM - 05:30 PM	Abstract	024 - NA
11:30 AM - 05:30 PM	Abstract	025 - NA
11:30 AM - 05:30 PM	Abstract	026 - NA
11:30 AM - 05:30 PM	Abstract	027 - Safety, tolerability, and cognitive and behavioral effects of long-term adjunctive lacosamide in children and adolescents with focal seizures
11:30 AM - 05:30 PM	Abstract	028 - Risk of Spontaneous Abortion in Women with Epilepsy: Where do Newer Antiepileptic Drugs Stand? Madhukar Trivedi, MD, MBBS
11:30 AM - 05:30 PM	Abstract	029 - Levetiracetam, Oxcarbazepine and Topiramate Clearance Changes During Pregnancy Paula E. Voinescu, MD
11:30 AM - 05:30 PM	Abstract	030 - Response to Pharmaceutical Formulation of Purified Cannabidiol (CBD) in Pediatric and Adult Patients with Treatment-Refractory Epilepsy Jerzy P. Szaflarski, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	031 - Predictors of Response to Placebo in Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL)
11:30 AM - 05:30 PM	Abstract	032 - Tuberous Sclerosis Complex (TSC) and Epilepsy Manifestations: the Impact of Refractory Epilepsy on Health-Related Quality of Life (HRQoL)
11:30 AM - 05:30 PM	Abstract	033 - Automated and Manual Diffusion Tractography in the Presurgical Evaluation of Patients with Temporal Lobe Epilepsy
11:30 AM - 05:30 PM	Abstract	034 - Surgical Success After Epilepsy Re-operations Ruta N. Yardi, MD
11:30 AM - 05:30 PM	Abstract	035 - Towards Improved Diagnosis in Epilepsy Robert Yao
11:30 AM - 05:30 PM	Abstract	036 - A Common Data Language for Clinical Research Studies: The National Institute of Neurological Disorders and Stroke Updates to Epilepsy Common Data Element Recommendations Joy R. Esterlitz
11:30 AM - 05:30 PM	Abstract	037 - Heart Rate Variability (HRV) from a 10-second Electrocardiogram (ECG) in Parkinson's Disease (PD) and Control Samuel Goldman, MD, MPH
11:30 AM - 05:30 PM	Abstract	038 - Non-motor Symptoms (NMS) Improvement is Positively Correlated with Baseline NMS Burden and Improved Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-carbidopa Intestinal Gel: A Post-hoc Analysis from the GLORIA Registry Werner Poewe, MD
11:30 AM - 05:30 PM	Abstract	039 - Effects of ADS-5102 on non-motor symptoms (NMS) in Parkinson's disease patients with dyskinesia Shyamal Mehta, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	040 - Clinical Experience with Pimavanserin for Treatment of Parkinson's Disease Psychosis Jessie Gibson, PhD, NP
11:30 AM - 05:30 PM	Abstract	041 - Color vision and contrast sensitivity in Parkinson Disease Gupta V. Harsh, MD
11:30 AM - 05:30 PM	Abstract	042 - A Network Meta-analysis of Droxidopa and Midodrine for the Treatment of Neurogenic Orthostatic Hypotension Jack J. Chen, PharmD BCPS CGP
11:30 AM - 05:30 PM	Abstract	043 - Cognitive performance and symptoms of anxiety, depression, and apathy in Parkinson's patients with and without mild cognitive Impairment.
11:30 AM - 05:30 PM	Abstract	044 - Patterns of responses on the Montreal Cognitive Assessment in Parkinson's Disease Associated Mild Cognitive Impairment Melissa Mackenzie, MD
11:30 AM - 05:30 PM	Abstract	045 - Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center Mary E. Finger
11:30 AM - 05:30 PM	Abstract	046 - The Prevalence and Characteristics of Probable REM behavior disorder in Thai Parkinson Patients. Patama Gomutbutra, MD
11:30 AM - 05:30 PM	Abstract	047 - Is Excessive Daytime Sleepiness Related to Nocturnal Sleep in Parkinson's Disease? Aliya Sarwar, MD
11:30 AM - 05:30 PM	Abstract	049 - Bilateral downward finger displacement in Parkinson disease may be a sign of worsening dementia and a bedside test to distinguish it from Alzheimer's disease Aman Deep, MD
11:30 AM - 05:30 PM	Abstract	050 - EEG findings in Parkinson disease patients with and without Visual Hallucinations: A Retrospective Case Control study Dharampreet Singh, MD
11:30 AM - 05:30 PM	Abstract	051 - No Postural Stability Differences between Asymptomatic and Symptomatic Neurological Orthostatic Hypotension in Parkinson's disease - A Pilot Study Victoria Smith
11:30 AM - 05:30 PM	Abstract	052 - Increased Frequency of Suicide In First Degree Relatives of LRRK2 G2019S Mutation Parkinson Disease
11:30 AM - 05:30 PM	Abstract	053 - A Multivariate Analysis of the Effects of Physical Activity and Cognition on Resting-State Brain Networks in Parkinson's Patients with and without Mild Cognitive Impairment Behnaz Jarrahi, PhD
11:30 AM - 05:30 PM	Abstract	054 - Preliminary evidence for an altered relationship between uric acid levels and resting state functional connectivity in REM sleep behavior disorder Mya C. Schiess, MD, FAAN
11:30 AM - 05:30 PM	Abstract	055 - Somatic items on the Beck Depression Inventory-II do not affect self-reported depression severity in Parkinson's disease Veronica Ramirez, BSc
11:30 AM - 05:30 PM	Abstract	056 - Defining Clinically Significant Fatigue in Parkinson's Disease
11:30 AM - 05:30 PM	Abstract	057 - Prevalence of spinocerebellar ataxia 36 in a US population
11:30 AM - 05:30 PM	Abstract	058 - Omaveloxolone Increases Nrf2 Activity, Reduces Inflammation, And Improves Mitochondrial Function In Cultured Cell Models Of Friedreich's Ataxia.
11:30 AM - 05:30 PM	Abstract	059 - Calcium derangement and STAU1-dependent ER stress in an in vitro model of SCA2 Mariana Gandelman, PhD
11:30 AM - 05:30 PM	Abstract	060 - Evaluation Of Various Movement Disorders In Patients Of Genetically Proven Spino Cerebellar Ataxia (SCA) : Study From A Tertiary Care Center In Northern India
11:30 AM - 05:30 PM	Abstract	061 - Characterization of The Brazilian ARSACS Phenotype: Clinical, Ophthalmological, Neuroimaging, and Genetic Features of Fourteen Cases.
11:30 AM - 05:30 PM	Abstract	062 - A Longitudinal Assessment of Spinocerebellar Ataxia types 1, 2, 3, 6 and 17 in Taiwan. Yicheng Lin, MD
11:30 AM - 05:30 PM	Abstract	063 - TRIO Gene Segregation in a Family with Cerebellar Ataxia Rana Hanna AL-Shaikh, MD
11:30 AM - 05:30 PM	Abstract	064 - A comparative study of the clinical and electrophysiological features between Friedreich ataxia and Ataxia with isolated vitamin E deficiency in Tunisia
11:30 AM - 05:30 PM	Abstract	065 - Quality of life in Spinocerebellar Ataxia type 10
11:30 AM - 05:30 PM	Abstract	066 - Quantitative oculomotor assessment and non-motor biomarkers in late-onset Tay-Sachs and Sandhoff disease Christopher D. Stephen, MB ChB, FRCP, MSc, SM
11:30 AM - 05:30 PM	Abstract	067 - Spinocerebellar Ataxias - Genotypical and Phenotypical Evaluation of 213 Brazilian Families Vinicius Oliveira Rocha Rodrigues
11:30 AM - 05:30 PM	Abstract	068 - Fragile X Low Normal Alleles are not associated with Cognitive Dysfunction in an Elderly Community Population Deborah H. Hall, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	069 - Relevance of Superior Vertical Ophthalmoparesis in the Diagnosis of Spinocerebellar Ataxia type 3
11:30 AM - 05:30 PM	Abstract	070 - Multimodal Neuroimaging Analysis in Brazilian Patients with SYNE1 Ataxia Maria Thereza Drumond Gama, MD
11:30 AM - 05:30 PM	Abstract	071 - Serum Anti-Gliadin Antibodies and The Risk of Cerebellar Ataxias: A Systematic Review and Meta-analysis Chi-Ying (Roy) Lin, MD, FAAN
11:30 AM - 05:30 PM	Abstract	072 - Sleep and Fatigue in Friedreich's Ataxia Addie Patterson, DO
11:30 AM - 05:30 PM	Abstract	073 - Lack of Placebo Effect in Fragile X-associated Tremor/Ataxia Syndrome Emily J. Hill, MD
11:30 AM - 05:30 PM	Abstract	074 - Upregulation of Mitochondrial Aldehyde Dehydrogenase Activity Inhibits Lipid Peroxidation in Friedreich's Ataxia Cells Jill S. Napierala, PhD
11:30 AM - 05:30 PM	Abstract	075 - Strong correlations observed among four measures of disease progression in Friedreich's ataxia
11:30 AM - 05:30 PM	Abstract	076 - Spinocerebellar ataxia type 2: The second most frequent dominant ataxia in Peru Erick Figueroa-Ildefonso
11:30 AM - 05:30 PM	Abstract	077 - Progressive motor and balance impairment in Spinocerebellar Ataxia type 10
11:30 AM - 05:30 PM	Abstract	078 - Cerebellar Degeneration and Progressive Ataxia Associated With HIV-Virus Infection Maria Thereza Drumond Gama, MD
11:30 AM - 05:30 PM	Abstract	079 - Nocturnal Hyperkinetic Spells in Dentatorubral Pallidoluysian Atrophy Deepmala Nandanwar, MD
11:30 AM - 05:30 PM	Abstract	080 - Autoimmune Cerebellar Ataxia Associated With Anti-GRAF1 Antibody Chaitanya Amrutkar, MD
11:30 AM - 05:30 PM	Abstract	082 - NA
11:30 AM - 05:30 PM	Abstract	083 - NA
11:30 AM - 05:30 PM	Abstract	084 - NA
11:30 AM - 05:30 PM	Abstract	085 - Is the neuroradiological differentiation between M. Fabry and MS possible? Paulus S. Rommer
11:30 AM - 05:30 PM	Abstract	086 - Quantitative Myelin Measurement in Brain White Matter Tracts of Rare Progressive Solitary Sclerosis, Compared to Multiple Sclerosis and Healthy Control Subjects Lisa Eunyoung Lee
11:30 AM - 05:30 PM	Abstract	087 - McArdle's sign: a specific sign of multiple sclerosis Brian G. Weinshenker, MD, FAAN
11:30 AM - 05:30 PM	Abstract	088 - Effective treatment of CLIPPERS with long-term use of rituximab Veronica P. Cipriani, MD, FAAN
11:30 AM - 05:30 PM	Abstract	089 - Pigeonholed: Misdiagnosis of an Unusual Presentation of NMO with Aquaporin Cross Reactivity to Cryptococcus spp. Steven Xian, MD
11:30 AM - 05:30 PM	Abstract	090 - Treatment-refractory anti-MOG antibody encephalomyelitis in an adult man Veronica P. Cipriani, MD, FAAN
11:30 AM - 05:30 PM	Abstract	091 - The Impact of Co-Morbid Sleep Apnea and Stroke on the Cost of Health Care Majaz Moonis, MD, FAHA, FAAN
11:30 AM - 05:30 PM	Abstract	092 - Screening for Sleep Apnea in Patients with Ischemic Stroke: A Quality Improvement Project Abby I. Metzler, MD
11:30 AM - 05:30 PM	Abstract	093 - Prevalence of High Risk Obstructive Sleep Apnea and Insomnia Ascertained by STOP and Insomnia Severity Index in Neurological Populations
11:30 AM - 05:30 PM	Abstract	094 - Performance Characteristics of Sleep Apnea Screening Instruments in Former Professional Athletes
11:30 AM - 05:30 PM	Abstract	095 - Treatment of Obstructive Sleep Apnea with Positive Airway Pressure in Mild Cognitive Impairment Aarushi Suneja, MD
11:30 AM - 05:30 PM	Abstract	096 - A Motivational and ��ɫ��al Toolkit to Improve CPAP Therapy Adherence: Feasibility of Organizational System Implementation Jamie P. Slettedahl, RN, NP, DNP
11:30 AM - 05:30 PM	Abstract	097 - Text Message Reminders and Intensive ��ɫ�� Improves Positive Airway Pressure Compliance and Cognition in Veterans with Traumatic Brain Injury and Obstructive Sleep Apnea: ANNIE Pilot Study Lynn Kataria, MD
11:30 AM - 05:30 PM	Abstract	098 - Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea with Depression: Associations in People With and Without Epilepsy Jocelyn Y. Cheng, MD, FAAN
11:30 AM - 05:30 PM	Abstract	099 - Polysomnography is Crucial to the Diagnosis of Sleep Disordered Breathing Syndromes in Patients with Hypermobility Spectrum Disorder Katherine G. Iannuzzelli
11:30 AM - 05:30 PM	Abstract	100 - Polysomnographic Characterization of Sleep Disturbance in Angelman Syndrome: a Case Series Jordan Broman-Fulks, MD
11:30 AM - 05:30 PM	Abstract	101 - Patients' Estimates of Their First Night Effects during in-Laboratory Polysomnography Using a Morning Questionnaire
11:30 AM - 05:30 PM	Abstract	102 - Expediting the Diagnosis of Obstructive Sleep Apnea by Increasing Awareness of the Sleep Laboratory Scheduling Process Micaela Nannery
11:30 AM - 05:30 PM	Abstract	103 - Improved primary CNS hypersomnia diagnosis with statistical machine learning Lan Jiang
11:30 AM - 05:30 PM	Abstract	104 - Supra-threshold EMG activity metric (STREAM) aids in discerning central disorders of hypersomnolence Brynn K. Dredla, MD
11:30 AM - 05:30 PM	Abstract	105 - The Nexus Narcolepsy Registry: Assessment of Sodium Oxybate (SXB) on Functioning, Productivity, and Health-Related Quality of Life in Participants With Narcolepsy Michael J. Thorpy, MD
11:30 AM - 05:30 PM	Abstract	106 - The Nexus Narcolepsy Registry: Factors Associated With Use of Different Medications and Discontinuation Rates in Participants With Narcolepsy
11:30 AM - 05:30 PM	Abstract	107 - Performance of the Patient Global Impressions - Severity Scale as a Self-reported Patient Assessment of Insomnia Severity William J. Herring, MD, PhD
11:30 AM - 05:30 PM	Abstract	108 - Poor Sleep Quality: A wake up call for the elderly at a tertiary care centre in Islamabad, Pakistan
11:30 AM - 05:30 PM	Abstract	109 - The Role of Prescription Drugs in REM Sleep Elahhe Afkhamnejad
11:30 AM - 05:30 PM	Abstract	110 - Gr8 Expectations: The Efficacy of BioBoosti 8 Minute Electromagnetic Cycles for the Treatment of Insomnia
11:30 AM - 05:30 PM	Abstract	111 - Melatonin Promotes Sleep by Inhibiting Orexinergic Neurons in Perifornical Lateral Hypothalamus Mahesh M. Thakkar
11:30 AM - 05:30 PM	Abstract	112 - Drosophila Myc is Involved in Fly Circadian Behavior Annie L. Hsieh, MD, PhD
11:30 AM - 05:30 PM	Abstract	113 - Pilot Study of Sleep/Wake Classification by Leg-Worn Actigraphy Thomas C. Ferree, PhD
11:30 AM - 05:30 PM	Abstract	114 - Eveningness Chronotype is Associated with Sleep Disturbances and Depressive Mood in Korean Working Adults
11:30 AM - 05:30 PM	Abstract	115 - Defining the Pattern of the Arousal-Related Motor-Behavioral Episodes (AMBEs) in Agrypnia Excitata (AE)-Limbic Autoinmune Encephalopathy (AE-LAE). Arturo Garay, MD
11:30 AM - 05:30 PM	Abstract	116 - Longitudinal connectome-base biomarker from Diffusion Tensor Imaging for REM Sleep Behavior Disorder Jessika Suescun, MD
11:30 AM - 05:30 PM	Abstract	117 - Sleep Duration and Cognitive Function: Associations in a Nationally Representative U. S. Sample Dominique Low, MD
11:30 AM - 05:30 PM	Abstract	118 - Let's Talk About Stroke: A Retrospective Descriptive Study
11:30 AM - 05:30 PM	Abstract	119 - Identification of Potential Triggering Factors for the Occurrence of Stroke: A case-crossover study Manya Prasad, MD
11:30 AM - 05:30 PM	Abstract	120 - Identifying predictors of stroke preparedness among a high risk church-going urban population: Findings from The Tailored Approaches to Stroke Health ��ɫ�� (TASHE) trial Mark Cort II, MD
11:30 AM - 05:30 PM	Abstract	121 - A Striking Preponderance of Hemorrhagic Strokes Among Young Africans: Evidence from the SIREN study. Fred Sarfo
11:30 AM - 05:30 PM	Abstract	122 - Association between Hospital Teaching Status and Iatrogenic Cerebrovascular Hemorrhage or Infarct
11:30 AM - 05:30 PM	Abstract	123 - Insight into the Burden of Opioids on Stroke Patient Outcomes in the United States Leila Parand, MD
11:30 AM - 05:30 PM	Abstract	124 - Changing Trends for Contraception in Women with Epilepsy Andrew G. Herzog, MD, MSc, FAAN
11:30 AM - 05:30 PM	Abstract	125 - A Neuroepidemiological Review of Childhood Epilepsy in a Children's Hospital Arayamparambil Anilkumar, MD, FAAN
11:30 AM - 05:30 PM	Abstract	126 - The Incidence of First Seizures, New Diagnosis of Epilepsy and Seizure Mimics in County Cork, Ireland; An Epidemiologic Protocol Eimer Maloney, MD
11:30 AM - 05:30 PM	Abstract	127 - Prevalence of Seizures in Patients with Systemic Lupus Erythematosus in Western Mexico. Adrian Rodriguez-Hernandez, MD
11:30 AM - 05:30 PM	Abstract	128 - Alcohol consumption and probable REM sleep behavior disorder: a community-based study Chaoran Ma
11:30 AM - 05:30 PM	Abstract	129 - Brain volumes and longitudinal cognitive change: a population-based study Deepti Vibha, MD
11:30 AM - 05:30 PM	Abstract	130 - Syphilis screening in Mild Cognitive Impairment: is it worth it?
11:30 AM - 05:30 PM	Abstract	131 - Relationship between central and peripheral presbycusis and mild cognitive impairment in a population-based study of Southern Italy: the "Great Age Study"
11:30 AM - 05:30 PM	Abstract	132 - Exploring the Potential Risk Factors of Neurodegenerative Disease in Autopsy Cases Patricia L. Henegan
11:30 AM - 05:30 PM	Abstract	133 - Effectiveness of a Multidisciplinary Neuropathy Clinic in Diagnosis and Treatment of Peripheral Neuropathy Martha L. Cruz, MD
11:30 AM - 05:30 PM	Abstract	134 - The Relationship Between Facial Nerve Palsy and Vaccination Venkatraman Thulasi, MD
11:30 AM - 05:30 PM	Abstract	135 - Title: Does Neurology Have a Role? Chemotherapy-Induced Peripheral Neuropathy from the Perspective of Breast Cancer Survivors Barbara S. Gordon-Kundu, MD
11:30 AM - 05:30 PM	Abstract	136 - Lumbosacral Radiculoplexus Neuropathy - Incidence and the association with Diabetes Mellitus. Peng Soon Ng, MBBS
11:30 AM - 05:30 PM	Abstract	137 - Ischemic Optic Neuropathies: a Case Series Study José Ángel Motos García
11:30 AM - 05:30 PM	Abstract	138 - The Danish National Epidemiology of Neuromyelitis Optica Spectrum Disorders Based On the 2015 International Panel for NMO Diagnosis (IPND) Criteria Viktoria Papp
11:30 AM - 05:30 PM	Abstract	139 - Interaction of alcohol consumption and smoking on Multiple Sclerosis severity course: a cross-sectional study Andrei Ivashynka, MD, PhD
11:30 AM - 05:30 PM	Abstract	140 - Epidemiology of multiple sclerosis in the United States Kanika Sharma, MD
11:30 AM - 05:30 PM	Abstract	141 - Mitochondrial disease phenotypes of 999 patients in the North American Mitochondrial Disease Consortium (NAMDC) Emanuele Barca, MD, PhD
11:30 AM - 05:30 PM	Abstract	142 - Psychology: A Truth in Neglect in Neuromuscular Clinics. A Meta-analysis of Mood Disorders in Myasthenia Gravis Clinics. Sankar Bandyopadhyay, MD, FAAN
11:30 AM - 05:30 PM	Abstract	143 - Epidemiology of War-related Spinal Cord Injury among Soldiers: A systematic Review Julio C. Furlan, MD, PhD, MBA, MSc, FAAN
11:30 AM - 05:30 PM	Abstract	144 - Differences in Comorbidity Phenotypes in Afghanistan and Iraq War Veterans with mild and no TBI: A Chronic Effects of Neurotrauma Consortium Study Mary Jo Pugh, PhD, RN, FAAN
11:30 AM - 05:30 PM	Abstract	145 - Trends of mortality in West Nile Neuroinvasive Disease (WNND) from 2005-2014 in a US hospital cohort. Monika Manchanda, MD
11:30 AM - 05:30 PM	Abstract	146 - Machine Learning Tools for Improving the Efficiency of Drug Development Clinical Trials in Neurodegenerative Diseases David L. Ennist, PhD
11:30 AM - 05:30 PM	Abstract	147 - Neurological Complications of Monoclonal Antibodies Pritikanta Paul, MD
11:30 AM - 05:30 PM	Abstract	148 - Four Patients with Numb Chin Syndrome and Important Malignancy-Related Considerations Gabriela Gilmour, MD
11:30 AM - 05:30 PM	Abstract	149 - A Case of Gait Ataxia and Ophthalmoparesis Fang Bai, MD
11:30 AM - 05:30 PM	Abstract	150 - Systemic Lupus Erythematosus Presenting as Rhombencephalitis Shafaq Mansoor, MD
11:30 AM - 05:30 PM	Abstract	151 - Guillain-Barré Syndrome in a Patient with Shingles Following Multiple Myeloma Treatment Sean Kennedy
11:30 AM - 05:30 PM	Abstract	152 - Anti-Ma-2 Encephalitis causes Obstructive Hydrocephalus Stephen W. English, MD
11:30 AM - 05:30 PM	Abstract	153 - Efficacy and Safety of Intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): the PRIMA and PATH studies Orell Mielke, MD
11:30 AM - 05:30 PM	Abstract	154 - Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis: A Case Report Andres De Leon, MD
11:30 AM - 05:30 PM	Abstract	155 - Acute immune-mediated polyneuropathies: The Royal North Shore Hospital experience Stephanie Barnes, MBBS
11:30 AM - 05:30 PM	Abstract	156 - A case of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy(GFAP) Meningo encephalomyelitis Ambihai Sivalingam
11:30 AM - 05:30 PM	Abstract	157 - Rheumatoid Meningitis presenting as Cough Headache Mary Clare McKenna, MB BCh BAO PhD
11:30 AM - 05:30 PM	Abstract	158 - Steroid-Responsive Hashimoto Encephalopathy and its association with von-Willebrand disease Roohi Katyal, MD
11:30 AM - 05:30 PM	Abstract	159 - A Tale of Two Thalami: A Case of Lupus Presenting as Central Neuropathic Pain Denise F. Chen
11:30 AM - 05:30 PM	Abstract	160 - Multiple antibody positive autoimmune encephalomyelitis; Role of immunosuppression in relapsing disease Sharmeen Hussaini, MBBS
11:30 AM - 05:30 PM	Abstract	161 - Anti-CASPR2 Associated Encephalitis, A Case Report
11:30 AM - 05:30 PM	Abstract	163 - Effect of Coexisting Autoimmune Disorders on Clinical Outcome in Guillain-Barre syndrome: An Analysis from National Inpatient Database Mohammed Qureshi, MD
11:30 AM - 05:30 PM	Abstract	165 - Inflammatory Pseudotumor of Skull Base with Intracranial Extension Mimicking Temporal Arteritis Mausaminben Y. Hathidara, MD
11:30 AM - 05:30 PM	Abstract	166 - Primary Angiitis of the Central Nervous System (PACNS): a 12-year single-center review Tan Guan Zhong
11:30 AM - 05:30 PM	Abstract	167 - Case Series of Polineuropathy and Monoclonal Gammopathy (POEMS) Nathane B. Rezende, MD
11:30 AM - 05:30 PM	Abstract	169 - Cruciate Paralysis: A Rare Brainstem-Cord Syndrome Jeanna West-Miles, DO
11:30 AM - 05:30 PM	Abstract	170 - NA
11:30 AM - 05:30 PM	Abstract	171 - NA
11:30 AM - 05:30 PM	Abstract	172 - NA
11:30 AM - 05:30 PM	Abstract	173 - The Left Parietal or "Acalculia" Variant of Early-Onset Alzheimer's Disease Negar Moheb, MD
11:30 AM - 05:30 PM	Abstract	174 - Early-Onset Progressive Dementia with Persistent Extensive Cortical Diffusion Restriction Juebin Huang, MD, PhD
11:30 AM - 05:30 PM	Abstract	175 - Peripheral Neuropathy in Patients with Prion Disease Han Wang, MD
11:30 AM - 05:30 PM	Abstract	176 - Representation of ethnic minorities in dementia trials: a systematic review and meta-analysis Manav Vyas, MD
11:30 AM - 05:30 PM	Abstract	177 - Posterior Cortical Atrophy with Quadrantic Spatial Neglect Usama Tariq, MBBS
11:30 AM - 05:30 PM	Abstract	178 - Hashimoto's Encephalitis Presenting as Normal Pressure Hydrocephalus Ellen C. Wong, MD
11:30 AM - 05:30 PM	Abstract	179 - EEG frequency changes during sleep in aMCI patients & healthy controls
11:30 AM - 05:30 PM	Abstract	180 - Attitudes towards research in persons of Mexican origin at-risk for autosomal dominant Alzheimer's disease
11:30 AM - 05:30 PM	Abstract	181 - Abnormal Nighttime Behaviours along the Spectrum of Alzheimer's Pathology Load David G. Munoz, MD
11:30 AM - 05:30 PM	Abstract	182 - Structural Basis of Psychosis in Cognitively Intact Subjects with Severe Alzheimer's Pathology David G. Munoz, MD
11:30 AM - 05:30 PM	Abstract	183 - Neuropathological and neuropsychological associations in hippocampal sclerosis of ageing; the 90+ study S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN
11:30 AM - 05:30 PM	Abstract	184 - Post-Mortem and In Vivo Assessment of Catecholaminergic Innervation and Alpha-Synuclein Deposition by Multi-Protein Immunofluorescence Microscopy Risa Isonaka
11:30 AM - 05:30 PM	Abstract	185 - Divergent Bi-hemispheric Patterns of FTLD-TDP and FTLD-Tau Neuropathologies in Primary Progressive Aphasia Lucia Giannini
11:30 AM - 05:30 PM	Abstract	186 - The Pathology of Rapid Cognitive Decline in Clinically Reported Alzheimer's Disease Christin Nance, BA
11:30 AM - 05:30 PM	Abstract	187 - Higher Circulating VEGF is Associated with Higher Burden of Neuritic Plaques in APOE ?4- Older Adults in the Framingham Study
11:30 AM - 05:30 PM	Abstract	188 - Grey Matter Atrophy as a Marker for Increasing Pathological Burden in TDP-43 Proteinopathies
11:30 AM - 05:30 PM	Abstract	189 - Definite Cerebral Amyloid Angiopathy related granulomatous inflammation in a middle-aged man with Homozygous alleles for ApoE4. Yan Hou, PhD, MB
11:30 AM - 05:30 PM	Abstract	190 - fMRI Surrogate of Cerebral Vascular Reactivity is Impaired in Cerebral Amyloid Angiopathy but Not Alzheimer's Disease Aaron R. Switzer, MD
11:30 AM - 05:30 PM	Abstract	191 - Poststroke Mild Cognitive Impairment and Dementia: a meta-analysis. Prominent role of criterion of cognitive deficit Olivier Godefroy, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	192 - Endothelial CTACK associated with an altered cerebral vasoreactivity in Alzheimer Disease. Juan F. Gongora Rivera, MD, MD, MSc, PhD
11:30 AM - 05:30 PM	Abstract	193 - 24-hour ambulatory blood pressure, cognitive performance, and cerebral microbleeds in the elderly
11:30 AM - 05:30 PM	Abstract	194 - Dementia and vascular risk scores in an aging population: an association with cognitive and sensory impairment
11:30 AM - 05:30 PM	Abstract	195 - Elucidating Subtypes and Risk Factors of Brain Arteriolosclerosis Eseosa Ighodaro, MD, PhD
11:30 AM - 05:30 PM	Abstract	196 - Blood pressure and the risk of dementia: a systematic review and dose-response meta-analysis of prospective studies Wei Xu
11:30 AM - 05:30 PM	Abstract	197 - Features Can Be Bound in Blindsight Without Consciousness Chaipat Chunharas
11:30 AM - 05:30 PM	Abstract	198 - Capgras Syndrome in a 20-Year-Old Woman with DiGeorge Syndrome and Diffuse Brain Calcifications Julien Cavanagh, MD
11:30 AM - 05:30 PM	Abstract	199 - What Day is Today? A Case of a Patient who Developed Significant Anterograde Amnesia with Abnormal Signal Intensity in the Medial Temporal Lobes on Brain Magnetic Resonance Imaging (MRI) in the Setting of Substance Abuse. Dena Williams, DO
11:30 AM - 05:30 PM	Abstract	200 - Unusual Amnestic Syndrome Associated with Combined Fentanyl and Cocaine Overdose Quynh Vo, MD
11:30 AM - 05:30 PM	Abstract	201 - Timing Of Anticoagulation In Patients With Cerebral Venous Thrombosis Requiring Neurosurgery: Case Series Russell E. Bartt, MD, FAAN
11:30 AM - 05:30 PM	Abstract	202 - Cerebral Venous Thrombosis (CVT) presenting symptoms in Native Americans and Hispanics. Saif A. Bushnaq, MD
11:30 AM - 05:30 PM	Abstract	203 - Endovascular Venous Sinus Stenting for Refractory Idiopathic Intracranial Hypertension: A Systematic Review of the Literature Brandon Bond, MD
11:30 AM - 05:30 PM	Abstract	204 - An Observational Study, On Low Molecular Weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) Therapy In The Treatment Of Cerebral Venous Sinuses Thrombosis (CVST) Sai Sripada R. Koneru, Sr., MD
11:30 AM - 05:30 PM	Abstract	205 - Cerebral Venous Thrombosis in Older Patients
11:30 AM - 05:30 PM	Abstract	206 - Cerebral Venous Sinus Thrombosis: Clinical Outcomes in Medical Management and Mechanical Thrombectomy Quang D. Vu, MD
11:30 AM - 05:30 PM	Abstract	207 - Suspicion of cerebral venous thrombosis based on the patient's headache characteristics Vanessa Rizelio
11:30 AM - 05:30 PM	Abstract	208 - Cerebral Venous Sinus Thrombosis: Predictors of Poor Clinical Outcomes Bryan J. Neth, MD, PhD
11:30 AM - 05:30 PM	Abstract	209 - Trans- Venous Aphasias Balasubramanian Samivel, MD
11:30 AM - 05:30 PM	Abstract	210 - Characteristics of Prehospital Acute Stroke Care in an Urban Setting: Pilot Data from the Pre-hospital Rapid Evaluation via Ambulance Lead Emergency Remote Telemedicine (PRE-ALERT) Study Mariko Hanson, MD
11:30 AM - 05:30 PM	Abstract	211 - Rapid Arterial Occlusion Evaluation Score Agreement Between Emergency Medical Services Providers and Stroke Specialized Neurologists Rahul H. Rahangdale, MD
11:30 AM - 05:30 PM	Abstract	212 - Using the RE-AIM Framework in Formative Evaluation/Planning of a Mobile Prehospital Telestroke Intervention in an Urban Setting: Pilot Data for the Prehospital Rapid Evaluation via Ambulance Lead Emergency Remote Telemedicine (PRE-ALERT) Study
11:30 AM - 05:30 PM	Abstract	213 - Predictors for prehospital time delay in patients with acute stroke in Germany Katja Kolpatzik
11:30 AM - 05:30 PM	Abstract	214 - Air Transport Shortens Arrival Times and May Increase Thrombectomy Rates Nitish Kumar, MD
11:30 AM - 05:30 PM	Abstract	215 - Then and Now: Temporal Evolution of a Mobile Stroke Unit Lila E. Sheikhi, MD
11:30 AM - 05:30 PM	Abstract	216 - Pre-Hospital Stroke Diagnosis Accuracy: Cross Sectional comparison 2010/11 & 2016 Michael J. Schneck, MD, FAAN
11:30 AM - 05:30 PM	Abstract	217 - Door-to-CT time: A Novel Tool to Assess Effect of Prehospital Notification of Acute Stroke Patients in a High Volume Comprehensive Stroke Center.
11:30 AM - 05:30 PM	Abstract	218 - College Student Led One-on One Stroke education: A Model to Increase EMS Prehospital Notification for Acute Ischemic Stroke.
11:30 AM - 05:30 PM	Abstract	219 - Anatomical variations circle Willis, aneurisms correlation, and relationship with subarachnoid haemorrhage Kledisa Shemsi
11:30 AM - 05:30 PM	Abstract	220 - Convexity Subarachnoid Hemorrhage: Clinical Features and Etiology of an Argentinian Cohort Anibal Chertcoff
11:30 AM - 05:30 PM	Abstract	221 - Defining clinical and radiological features of nontraumatic convexal subarachnoid hemorrhage in a cohort of 60 Argentinean patients Federico Eberbach
11:30 AM - 05:30 PM	Abstract	222 - Change in outpatient post-discharge clinic follow-up for aneurysmal subarachnoid hemorrhage patients over 5-year period - a single center perspective Danny Samkutty, MD
11:30 AM - 05:30 PM	Abstract	223 - Increased Rate of Subarachnoid Hemorrhage and Aneurysm Size in Patients with Obstructive Sleep Apnea Sebastian Zaremba, MD
11:30 AM - 05:30 PM	Abstract	224 - Early Inflammation as a Predictor of Vasospasm after Subarachnoid Hemorrhage Muhammad Rizwan Husain, MD
11:30 AM - 05:30 PM	Abstract	225 - Serum lactate and cerebral vasospasm in subarachnoid hemorrhage. Sequential transcranial doppler in a Hispanic cohort. A preliminary study Leticia Alejandra Olguín-Ramírez, Jr.
11:30 AM - 05:30 PM	Abstract	226 - Subarachnoid Hemorrhage in the Setting of Electroconvulsive Therapy in a Patient with an Unsecured Cerebral Aneurysm: A Case Report and Review of the Literature James J. Gugger, Jr., MD, PharmD
11:30 AM - 05:30 PM	Abstract	227 - Diabetic Patients with Non-Aneurysmal Subarachnoid Hemorrhage - A Single Center Perspective Amna Sohail, MD
11:30 AM - 05:30 PM	Abstract	228 - The Rise of Non Aneurysmal Subarachnoid Hemorrhages in the United States: Analysis of Nationwide Inpatient Sample from 2006 to 2014
11:30 AM - 05:30 PM	Abstract	229 - Natural History of Infectious Intracranial Aneurysms Undergoing Antibiotic Treatment Cory J. Rice, MD
11:30 AM - 05:30 PM	Abstract	230 - Sulcal SAH in patients with infective endocarditis : A predictive imaging finding for perioperative neurologic complications? Lucy Zhang, MD
11:30 AM - 05:30 PM	Abstract	231 - Procedures requiring general anesthesia in patients with unruptured intracranial aneurysms. Vijayaleskhmi Nair, MD
11:30 AM - 05:30 PM	Abstract	232 - Microhemorrhages and Cerebral Amyloid Angiopathy: Worth Counting? Joseph F. Carrera, MD
11:30 AM - 05:30 PM	Abstract	233 - Transient Focal Neurological Episodes with Subsequent Catastrophic Intracerebral Hemorrhage Due To Cortical Superficial Siderosis and Amyloid Angiopathy Davida Goltz, MD
11:30 AM - 05:30 PM	Abstract	234 - Clinical Characteristics of 100 patients with Angiography-confirmed Low-flow Spinal Arteriovenous Fistulas Olwen Murphy, MD
11:30 AM - 05:30 PM	Abstract	235 - Aspirin and anticoagulant usage on outcomes after ruptured arteriovenous malformation: a Nationwide Inpatient Sample analysis Rakesh Khatri, MD, FAAN
11:30 AM - 05:30 PM	Abstract	236 - Cerebral Hemangiomas: 53 Times More Likely To Bleed Dinesh V. Jillella, MD
11:30 AM - 05:30 PM	Abstract	237 - Intracranial Hemorrhage in Familial Cerebral Cavernous Malformation: Clinical presentation vs. incidental MRI findings in the follow-up Imaging Nazeem Arsalan, MD
11:30 AM - 05:30 PM	Abstract	238 - Role of Lamotrigine in Management of Commonly Encountered Symptoms in Patients with Cerebral Cavernous Malformations Piotr Bzdyra, MD
11:30 AM - 05:30 PM	Abstract	239 - Risk factors associated with acute symptomatic seizures in patients with intracerebral hemorrhage: A case-control study Ting Wu, MD
11:30 AM - 05:30 PM	Abstract	240 - Validating the role of Prophylactic Antiepileptic Drugs (AEDs) in Cortical Intracranial Hemorrhage in a Large Urban Hospital. Anusha Boyanpally, MBBS
11:30 AM - 05:30 PM	Abstract	241 - Distal Brain Alteration and Delayed Cognitive Impairment Following Intracerebral Hemorrhage Elaine Shi
11:30 AM - 05:30 PM	Abstract	242 - The Impact of Left versus Right Sided Strokes on Intracerebral Hemorrhage Russell E. Bartt, MD, FAAN
11:30 AM - 05:30 PM	Abstract	243 - Role of Flat Panel Cone Beam Computed Tomography in Detecting ICH: Single Center Study Amrinder Singh, MD
11:30 AM - 05:30 PM	Abstract	244 - Primary Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas: a Case-Control Study Hannah Irvine, MD
11:30 AM - 05:30 PM	Abstract	245 - Multifocal Hemorrhagic Brain Lesions and Leukoencephalopathy Due to Acute Disseminated Intravascular Coagulation Andrew Lin, MD
11:30 AM - 05:30 PM	Abstract	246 - Acute Hyperglycemia is Associated with Larger Antithrombotic-Related Intracerebral Hemorrhage Volume Himanshu Gupta, MD
11:30 AM - 05:30 PM	Abstract	247 - Characterization of Atrial Fibrillation in Antithrombotic-Related Intracerebral Hemorrhage Simon Beshara, MD, PhD
11:30 AM - 05:30 PM	Abstract	248 - Elevated Serum Troponin Levels Predict Worse Outcome After Intracerebral Hemorrhage Gabriela Trifan, MD
11:30 AM - 05:30 PM	Abstract	249 - Thromboelastography with Platelet Mapping (TEG-PM) in Patients with Spontaneous Intracerebral Hemorrhage on Antiplatelet Therapy-Validity and application of Testing Premkumar Nattanmai Chandrasekaran, MD
11:30 AM - 05:30 PM	Abstract	250 - Benign Intracerebral Hemorrhage: Proposal for a New Definition and Association with Functional Independence Qi Li, MD, PhD
11:30 AM - 05:30 PM	Abstract	251 - Comparison of Clinical and Radiological Characteristics of Warfarin versus Novel Oral Anticoagulant Related Intracerebral Hemorrhages Malgorzata Miller, MD
11:30 AM - 05:30 PM	Abstract	252 - Remote Cerebellar Hemorrhage: Report of Two Cases and Systematic Literature Review Guilherme S. Torezani, MD
11:30 AM - 05:30 PM	Abstract	253 - The Spot Sign in Intraventricular Hemorrhage: Prevalence and Relation to Hematoma Expansion
11:30 AM - 05:30 PM	Abstract	254 - Evaluation of Prothrombin Complex Concentrate on Oral Anticoagulation Associated Intracerebral Hemorrhage
11:30 AM - 05:30 PM	Abstract	255 - Modifiable Factors are a Major Cause of Non-traumatic Intracerebral Hemorrhage in Young Adults Matthew Broderick, MD
11:30 AM - 05:30 PM	Abstract	256 - A Decade of Intracerebral Hemorrhage in the United States: The Impact of Teaching Institutions Sheetal Hegde, MD
11:30 AM - 05:30 PM	Abstract	257 - Improving appropriate use of DVT prophylaxis in spontaneous ICH patients Aparna M. Prabhu, MD
11:30 AM - 05:30 PM	Abstract	258 - Intracranial Injuries in the Burn Intensive Care Unit Brian Stephens, MD
11:30 AM - 05:30 PM	Abstract	259 - Extrapolation of Adjunctive Efficacy and Safety Data from Phase III Partial Epilepsy Trials to Evaluate Perampanel as Monotherapy Scott Mintzer, MD
11:30 AM - 05:30 PM	Abstract	260 - Clinical Factors Associated with a Major Response (?75% Reduction in Seizure Frequency/28 Days) in Phase III Trials of Adjunctive Perampanel in Patients with Partial Seizures: Post Hoc Multivariate Analysis Elinor Ben-Menachem, MD, FAAN
11:30 AM - 05:30 PM	Abstract	261 - Effect of Common Concomitant Antiepileptic Drugs (AEDs) During Adjunctive Treatment with Perampanel: Post Hoc Analysis from the Open-Label Extension (OLEx) of a Phase III Study in Patients with Idiopathic Generalized Epilepsy (IGE) Terence J. O'Brien, MD
11:30 AM - 05:30 PM	Abstract	262 - One-year Retention Study of Adjunctive Perampanel Treatment in Epilepsy Patients
11:30 AM - 05:30 PM	Abstract	263 - Pharmacokinetic Evaluations of ADS-4101 (Lacosamide) Modified Release Capsules versus Lacosamide IR in Two Phase 1 Studies up to 600 mg Rajiv Patni, MD
11:30 AM - 05:30 PM	Abstract	264 - Long-term Safety and Efficacy of Cannabidiol (CBD) in Patients with Lennox-Gastaut Syndrome (LGS): Results from Open-label Extension Trial (GWPCARE5) Jonathan J. Halford, MD, FAAN
11:30 AM - 05:30 PM	Abstract	265 - Acute Treatment of Prolonged and Repetitive Seizures in Adults Using Sublingual Administration of Lorazepam Intensol 2 mg/ml Solution Charlotte Kwok
11:30 AM - 05:30 PM	Abstract	266 - A randomized, double-blind, placebo-controlled, crossover study to evaluate the abuse potential of purified cannabidiol (CBD) in subjects with a history of recreational polydrug use Kerri Schoedel
11:30 AM - 05:30 PM	Abstract	267 - Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: An Interim Analysis Robert T. Wechsler, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	268 - Assessment of the Long-Term Efficacy and Safety of Adjunctive Perampanel in Adolescent Patients: Post Hoc Analysis of Open-Label Extension (OLEx) Studies Jesus E. Pina-Garza, MD
11:30 AM - 05:30 PM	Abstract	269 - Third-Line Antiepileptic Treatment Outcomes in Refractory Status Epilepticus Steven P. Ellis, Jr., MD
11:30 AM - 05:30 PM	Abstract	270 - Time to Pre-randomization Monthly Seizure Count for Perampanel in Patients with Primary Generalized Tonic-Clonic (PGTC) Seizures: A Potential New Clinical Endpoint Jacqueline French, MD, FAAN
11:30 AM - 05:30 PM	Abstract	271 - Exposure-Response Analysis of Cannabidiol (CBD) Oral Solution for the Treatment of Lennox-Gastaut Syndrome
11:30 AM - 05:30 PM	Abstract	272 - Post Hoc Analysis of Rufinamide Study 303: Seizure-Free Days in Patients with Lennox-Gastaut Syndrome (LGS)
11:30 AM - 05:30 PM	Abstract	273 - Efficacy and Safety of Adjunctive Rufinamide in Lennox-Gastaut Syndrome (LGS): Results from Studies 022, 022E, 303, 304, and 305
11:30 AM - 05:30 PM	Abstract	274 - Seizure Outcome After Lesional Epilepsy Surgery: a Report of the First Comprehensive Epilepsy Surgery Program in Iran Shervin Badihian, MD
11:30 AM - 05:30 PM	Abstract	275 - Seizure Outcome after Epilepsy Surgery in a Developing Country using a Non Invasive Presurgical Evaluation Protocol Jayanthi Mani, MD
11:30 AM - 05:30 PM	Abstract	276 - Magnetoencephalography in Epilepsy surgery: Concordance and Yield Arunmozhimaran Elavarasi, MD
11:30 AM - 05:30 PM	Abstract	277 - Utilization of epilepsy surgery in the United States, 2009?2014 Ahyuda Oh, PhD
11:30 AM - 05:30 PM	Abstract	278 - Functional Connectivity of Idiopathic Generalized Epilepsy Patients vs Frontal Epilepsy Patients using Magnetoencephalography (MEG) Sira Carrasco
11:30 AM - 05:30 PM	Abstract	279 - Altered Frontal Lobe Network Function in Temporal Lobe Epilepsy Revealed by Graph Theory Analysis Shankar Iyer
11:30 AM - 05:30 PM	Abstract	280 - ECG reporting inthe first seizure clinic: Are we missing an opportunity? Xuya Huang, MBBS, PhD
11:30 AM - 05:30 PM	Abstract	281 - Surface EMG from the Brain Sentinel® Monitoring and Alerting System for classification of seizure events Jose E. Cavazos, MD, PhD
11:30 AM - 05:30 PM	Abstract	282 - Provider and Patient SUDEP-7 Scoring: A Prospective Pilot Study Allison Kiernan
11:30 AM - 05:30 PM	Abstract	283 - On the Feasibility of Natural Language Processing for Standardized Data Extraction from Electronic Medical Records of Epilepsy Patients Pouya Khankhanian, MD
11:30 AM - 05:30 PM	Abstract	284 - Reliability of Patient-Reported Peri-Ictal Behavior to Identify Psychogenic Nonepileptic Seizures Wesley Kerr, MD, PhD
11:30 AM - 05:30 PM	Abstract	285 - PAP Therapy is Challenging for Epilepsy Patients Veronique Latreille, PhD
11:30 AM - 05:30 PM	Abstract	286 - Association of Photoplethysmography (PPG) signals and seizures in patients with epilepsy
11:30 AM - 05:30 PM	Abstract	287 - Utilization of Continuous Video Electroencephalogram and Predictors of Poor Outcomes in Non-Convulsive Epilepsy. Urvish K. Patel
11:30 AM - 05:30 PM	Abstract	288 - Reversible Complete Blindness due to Bilateral Status Epilepticus Amauroticus Secondary to Hyperglycemia Dennis Chuang, MD, PhD
11:30 AM - 05:30 PM	Abstract	289 - First Reported Case of Alice in Wonderland Syndrome Due to an Arteriovenous Malformation Veeresh Kumar Nanjangud Shivamurthy, MBBS
11:30 AM - 05:30 PM	Abstract	290 - The Importance of Early Immunotherapy in patients with Faciobrachial Dystonic Seizures Julia E. Thompson, MD
11:30 AM - 05:30 PM	Abstract	291 - NA
11:30 AM - 05:30 PM	Abstract	292 - NA
11:30 AM - 05:30 PM	Abstract	293 - NA
11:30 AM - 05:30 PM	Abstract	294 - NA
11:30 AM - 05:30 PM	Abstract	295 - Thermolabile Carnitine Palmitoyltransferase II (CPT2) variant susceptibility in influenza-associated encephalopathy - a case report Wing Cheong Lee, MBBS
11:30 AM - 05:30 PM	Abstract	297 - Pitt-Hopkins Syndrome: A 23-Patient Case Series Kimberly Goodspeed, MD
11:30 AM - 05:30 PM	Abstract	298 - GTPBP3 Mutation Leading Recurrent Lactic Acidosis Associated with Vomiting and Headache Gozde Erdemir, MD
11:30 AM - 05:30 PM	Abstract	299 - Intra-familial variability associated with recessive mutations in MTO1 gene. Valentina Emmanuele, MD, PhD
11:30 AM - 05:30 PM	Abstract	300 - Compound Heterozygotes with Three Disparate Orphan Diseases: Pyridoxine Dependent Epilepsy, Ataxia Telangiectasia, and Tay Sachs Disease Richard S. Young, MD, FAAN
11:30 AM - 05:30 PM	Abstract	301 - Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome Caterina Garone
11:30 AM - 05:30 PM	Abstract	302 - The Role of Autophagy Dysfunction and Mitochondrial Depolarization in Neuronal Death in hiPSC-derived Niemann-Pick Type C1 Neurons Emma Wu
11:30 AM - 05:30 PM	Abstract	303 - Yield of Genetic Testing Including Targeted Gene Panel in a Clinical Population of Children with Autism Spectrum Disorder Louisa Kalsner, MD
11:30 AM - 05:30 PM	Abstract	304 - Exome and genome sequencing results refine diagnoses and provide treatment options in a cohort of New Zealanders with neurodevelopmental disorders Rosamund A. Hill, FRACP
11:30 AM - 05:30 PM	Abstract	305 - Insights Into a Rare Genetic Disease: Unique Behavioral Phenotype in PURA-related Neurodevelopmental Disorders Christina Chrisman, MD
11:30 AM - 05:30 PM	Abstract	306 - Recessive mutations in SLC13A5 result in a loss of citrate transport and cause refractory epilepsy/status epilepticus, developmental delay and progressive microcephaly Abdulaziz M. Alghamdi, MBBS
11:30 AM - 05:30 PM	Abstract	307 - Clinical phenotypic data is a key factor necessary to improve molecular interpretation of de novo alterations in neurodevelopmental genetic testing
11:30 AM - 05:30 PM	Abstract	308 - Diagnostic Exome Sequencing in Adolescents with Neurological and Neurodevelopmental Disorders
11:30 AM - 05:30 PM	Abstract	309 - Quantitative Measures of Motor Function in children with Duplications of 15q11.3-13.1 (Dup15q Syndrome) and Typically Developing (TD) Children Rujuta B. Wilson, MD
11:30 AM - 05:30 PM	Abstract	310 - Expanding the phenotype of ATP1A3 mutations with newly described abnormalities on brain MRI Janet Elgallab, MD
11:30 AM - 05:30 PM	Abstract	311 - Novel Phenotype of ATP1A3 Mutation Starting in Infancy Jason B. Richards, MD
11:30 AM - 05:30 PM	Abstract	312 - Acroparesthesia may be of Mitochondrial Origin Jose-Rafael P. Zuzuarregui, MD
11:30 AM - 05:30 PM	Abstract	313 - Clinical utility of next generation sequencing in pediatric neurology Priyanka Madaan
11:30 AM - 05:30 PM	Abstract	314 - Argentinian Clinical Genomics in a Leukodystrophies and Genetic Leukoencephalopathies cohort: diagnostic yield in our first nine years Leila Cohen
11:30 AM - 05:30 PM	Abstract	315 - Clinicoradiological Improvement in MELAS after L-Arginine Therapy Dominic A. Hovsepian, MD
11:30 AM - 05:30 PM	Abstract	316 - Neurological Therapeutic goals in Fabry Disease: European Expert Consensus Recommendations Max J. Hilz, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	317 - Fatal Familial Insomnia in a Canadian family Nathaniel Bendahan, MD
11:30 AM - 05:30 PM	Abstract	318 - Potential role of gut microbiota in Amyotrophic Lateral Sclerosis (ALS) pathogenesis Fabiola De Marchi
11:30 AM - 05:30 PM	Abstract	319 - To Study Clinical, Histological And Radiological Features In Neurological Mitochondrial Disorders Nishita Singh, Sr., MD
11:30 AM - 05:30 PM	Abstract	320 - ANXA11 mutations prevail in Chinese amyotrophic lateral sclerosis patients with and without cognitive dementia Kang Zhang
11:30 AM - 05:30 PM	Abstract	321 - Transcriptional profiling of Primary Progressive Multiple Sclerosis patients identifies Fast and Slow progression patterns Michael Gurevich
11:30 AM - 05:30 PM	Abstract	322 - Niemann Pick Disease (NPD) presenting as cortical venous sinus thrombosis: a rare presentation Leenu Gupta, MBBS MD
11:30 AM - 05:30 PM	Abstract	323 - Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
11:30 AM - 05:30 PM	Abstract	324 - Open Label Extension of the Phase 3 Study NEURO-TTR to Assess the Long-term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis Thomas Brannagan III, MD, FAAN
11:30 AM - 05:30 PM	Abstract	325 - In vivo Safety and Efficacy of a 3rd generation Antisense Oligonucleotide targetting TGF-ßRII to treat Amyotrophic Lateralsclerosis
11:30 AM - 05:30 PM	Abstract	326 - A Refined Brain Database to Study Transcriptomic Changes in Neurological Disease
11:30 AM - 05:30 PM	Abstract	327 - Blood Volatile Organic Compounds Related to Oxidative Stress as Potential Biomarkers for Huntington's disease Hongquan Jiang, MD
11:30 AM - 05:30 PM	Abstract	328 - Human systems analysis implicates disturbed pathways associated with cognitive dysfunction in Williams Syndrome and shared in Autism
11:30 AM - 05:30 PM	Abstract	329 - VPS35 and Hydrocephalus of the Developing Mouse Brain. HyunJin Song
11:30 AM - 05:30 PM	Abstract	330 - Cerebellar Ataxia Renal-failure Neuropathy with Encephalopathy (mt-CARNE): A New Mitochondrial Syndrome Identified by Sequencing Frozen Nerve and Kidney Tissue DNA Peng Soon Ng, MBBS
11:30 AM - 05:30 PM	Abstract	331 - Burden of Hereditary Transthyretin Amyloidosis With Polyneuropathy in Patients Enrolled in the Phase 3 Study NEURO-TTR John L. Berk
11:30 AM - 05:30 PM	Abstract	332 - Clinical and Molecular Characterization of Hereditary Spastic Paraplegias: A Next-Generation Sequencing Panel Approach
11:30 AM - 05:30 PM	Abstract	333 - MiR-218 as a candidate of biomarker for early diagnosis of ALS. Sandra Diaz Garcia, PhD
11:30 AM - 05:30 PM	Abstract	334 - NA
11:30 AM - 05:30 PM	Abstract	335 - NA
11:30 AM - 05:30 PM	Abstract	336 - NA
11:30 AM - 05:30 PM	Abstract	337 - NA
11:30 AM - 05:30 PM	Abstract	338 - NA
11:30 AM - 05:30 PM	Abstract	339 - A Portable Wireless Motion Capture System for Patients with Myotonic Dystrophy Tekalign Burka, MD
11:30 AM - 05:30 PM	Abstract	340 - A Retrospective Study of Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Identifying Ultrasonographic Features for Diagnosis and Prognosis Nicholas Crump, MD
11:30 AM - 05:30 PM	Abstract	341 - Is high-resolution fascicular nerve ultrasound an upcoming obligation in the neurological diagnostic algorithm? Anna Grisold, MD
11:30 AM - 05:30 PM	Abstract	343 - Prevalence and Incidence Rates of Autonomic Disorders among U.S. Military Healthcare System Beneficiaries Never Diagnosed with Diabetes Glen A. Cook, Jr., MD, FAAN
11:30 AM - 05:30 PM	Abstract	344 - Whipple's disease - an unusual etiology for neurologic disease Mohammad A. Kabir, MD
11:30 AM - 05:30 PM	Abstract	345 - The clinical features and pathophysiology of ataxic form of Hashimoto's encephalopathy Makoto Yoneda
11:30 AM - 05:30 PM	Abstract	346 - Primary Angiitis of the Central Nervous System with Unusual Imaging Characteristics Adam J. Margolius, MD
11:30 AM - 05:30 PM	Abstract	347 - Neurological spectrum of diseases associated with autoimmune thyroid disease: a case series to recognize diagnostically helpful signs. Ehad Afreen, MD
11:30 AM - 05:30 PM	Abstract	348 - Neurosurgical Awakening of Cerebral Adrenoleukodystrophy: Phenotypes, Predictors, and Prevention Na Tosha N. Gatson, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	349 - Neurosarcoidosis Flare with Multifocal Restricted Diffusion: Stroke, Inflammation, or Both? Elizabeth Spurgeon, MD
11:30 AM - 05:30 PM	Abstract	350 - Quantifying Retinal Layers in CASPR2 Antibody Syndrome with Optical Coherence Tomography (OCT) Clarice Zhou, BS
11:30 AM - 05:30 PM	Abstract	351 - Propensity Score Matched Comparative Effectiveness Analysis of Dimethyl Fumarate Relative to Interferon, Glatiramer Acetate, or Teriflunomide Treated RRMS Outpatients in the German NeuroTransData Registry Arnfin Bergmann
11:30 AM - 05:30 PM	Abstract	352 - Comparing Efficacy between Natalizumab and Fingolimod: Radiological Findings from BEST-MS Study Mikael Cohen
11:30 AM - 05:30 PM	Abstract	353 - Relapse in Patients with Multiple Sclerosis Newly Initiating scIFN?1a Compared with Oral Disease-Modifying Drugs: A Real-World Assessment James D. Bowen, MD
11:30 AM - 05:30 PM	Abstract	354 - A Panel Survey Analysis of Adherence in Patients with Multiple Sclerosis Treated with scIFN?1a or Dimethyl Fumarate Amy P. Perrin Ross, RN, APN MSN, CNRN
11:30 AM - 05:30 PM	Abstract	355 - Comparative Effectiveness of Teriflunomide and Dimethyl Fumarate in Patients With Relapsing Forms of MS in the Real-World Teri-RADAR Study Robert Zivadinov, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	357 - Effect of previous therapies on treatment retention and satisfaction in patients randomized to fingolimod or injectable disease-modifying therapies in PREFERMS Florian P. Thomas, MD, PhD, MA, FAAN
11:30 AM - 05:30 PM	Abstract	358 - Observational, retrospective study in relapsing-remitting multiple sclerosis to compare the effectiveness of second line treatments Fingolimod and Natalizumab in Spanish clinical practice Francisco Javier Ricart
11:30 AM - 05:30 PM	Abstract	360 - Peginterferon Beta-1a Demonstrated Better Clinical Outcomes Than Teriflunomide in Newly Diagnosed Relapsing Multiple Sclerosis (RMS) Patients: A Matching-Adjusted Comparison of Phase 3 Trial Data Scott D. Newsome, DO, FAAN
11:30 AM - 05:30 PM	Abstract	361 - Demonstration of Equivalence of Generic Glatiramer Acetate (GA) Produced by Mylan to Copaxone®
11:30 AM - 05:30 PM	Abstract	362 - Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-World EFFECT Study
11:30 AM - 05:30 PM	Abstract	363 - Comparative Effectiveness and Discontinuation of Dimethyl Fumarate and Fingolimod in Two Large Academic Medical Centers at 24-Month Follow-Up: Sub-Group Analyses Carrie M. Hersh, DO, MSc, FAAN
11:30 AM - 05:30 PM	Abstract	364 - A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland
11:30 AM - 05:30 PM	Abstract	365 - Comparative effectiveness of dimethyl fumarate and fingolimod using fully automated algorithms to assess effects on brain atrophy and T2-lesion volume Jenny J. Feng, MD
11:30 AM - 05:30 PM	Abstract	366 - Annualized Relapse Rate and Confirmed Disability Progression in Patients Receiving Continuous Ocrelizumab or Switching From Interferon Beta-1a to Ocrelizumab Therapy in the Open-Label Extension Period of the Phase III Trials of Ocrelizumab in Patients With Relapsing Multiple Sclerosis Stephen L. Hauser, MD
11:30 AM - 05:30 PM	Abstract	367 - Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed and Other Early Multiple Sclerosis Patients, and Patients Switching from Interferon or Glatiramer Acetate, in Routine Medical Practice: Interim Results from ESTEEM Kathryn Giles
11:30 AM - 05:30 PM	Abstract	368 - Safety and efficacy of IV cladribine versus alemtuzumab in aggressive multiple sclerosis: a retrospective cohort study Gauruv Bose, MD
11:30 AM - 05:30 PM	Abstract	369 - A comparative effectiveness analysis applying a 3-way propensity score matching to real-world data from the MSBase registry in preparation for a cost-effectiveness model: patients switching within first-line agents or to either natalizumab or fingolimod in active relapsing-remitting multiple sclerosis (RRMS) Timothy Spelman
11:30 AM - 05:30 PM	Abstract	370 - Integrated Transcriptomic and Physicochemical Characterization of Glatiramer Acetate Products (Copaxone and Glatopa) Available in the United States
11:30 AM - 05:30 PM	Abstract	371 - Confirmed Disability Progression in Different Subgroups of Patients With Relapsing Multiple Sclerosis Who Received Ocrelizumab or Interferon Beta-1a in the Phase III OPERA I and OPERA II Studies Benjamin Turner, MD, MBBS
11:30 AM - 05:30 PM	Abstract	372 - Time to treatment failure following initiation of fingolimod versus teriflunomide for the treatment of multiple sclerosis: a retrospective U.S. claims study
11:30 AM - 05:30 PM	Abstract	373 - Propensity Score Matched Comparative Effectiveness Analysis of Dimethyl Fumarate Relative to Fingolimod-Treated RRMS Outpatients in the German NeuroTransData Registry Stefan Braune
11:30 AM - 05:30 PM	Abstract	374 - Comparative Effectiveness of Dimethyl Fumarate Versus Fingolimod and Teriflunomide on the Risk of Relapse in MS Patients Switching from First-Generation Platform Therapies in the US Jacqueline A. Nicholas, MD
11:30 AM - 05:30 PM	Abstract	375 - Injectable disease-modifying therapies cycling versus switching to fingolimod: a retrospective U.S. claims study of risk of MS related relapses
11:30 AM - 05:30 PM	Abstract	376 - Characterization and Comparison of the Gene Expression Profiles of Copaxone® and Mylan Glatiramer Acetate
11:30 AM - 05:30 PM	Abstract	377 - Patterns of Regional Gray Matter and White Matter Atrophy in Patients Starting Fingolimod or Natalizumab: A 2-Year Tensor-Based Morphometry Study Paolo Preziosa
11:30 AM - 05:30 PM	Abstract	378 - Cytokine changes induced by antiCD20 Infusions: A Comparison of Rituximab Versus Ocrelizumab Nassim Zanganeh, MS
11:30 AM - 05:30 PM	Abstract	379 - Patients switching to Fingolimod from other oral DMTs and different treatment frequencies in daily clinical routine: Results from PANGAEA 2.0 Tjalf Ziemssen, MD, FAAN
11:30 AM - 05:30 PM	Abstract	380 - Early versus Delayed Natalizumab for Multiple Sclerosis Devon Conway, MD
11:30 AM - 05:30 PM	Abstract	381 - Treatment Experiences of Patients with MS: Results From the Global vsMS™ Survey Ann D. Bass, MD
11:30 AM - 05:30 PM	Abstract	382 - Comparison of Rituximab vs Fingolimod, Dimethyl Fumarate and Natalizumab in the Treatment of Multiple Sclerosis: Two Year Experience Brandi L. Vollmer, MPH
11:30 AM - 05:30 PM	Abstract	383 - Serum neurofilament light chain levels are increased at the onset of PML in natalizumab treated MS patients Gloria Dalla Costa
11:30 AM - 05:30 PM	Abstract	384 - Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor Makoto Hara, MD
11:30 AM - 05:30 PM	Abstract	385 - Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects Sarah Fiedler
11:30 AM - 05:30 PM	Abstract	386 - Capsaicin Increases the Anti-inflammatory Potential of Myelinating Schwann Cells Thomas Grüter
11:30 AM - 05:30 PM	Abstract	387 - Analysis of lymphocyte counts and infection rates with fingolimod in patients with primary progressive multiple sclerosis over the INFORMS trial Edward Fox, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	388 - Mesenchymal Stem Cells from Patients with Secondary Progressive Multiple Sclerosis Show Deficient Immunomodulatory Activity towards Homologous Immune Cells Cris S. Constantinescu, MD, PhD
11:30 AM - 05:30 PM	Abstract	389 - Comparison of IL6 Levels in CNS Inflammatory Conditions according to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Status Sara Mariotto, MD, PhD
11:30 AM - 05:30 PM	Abstract	390 - Investigating Immune Phenotype Biomarker Changes in Patients with Relapsing MS Treated with Fingolimod 0.5 mg/day: The FLUENT Study Jeffrey A. Cohen, MD
11:30 AM - 05:30 PM	Abstract	391 - Recent Advances in Flow Cytometry Reveal Cellular Immune Dysregulation in MS and NMOSD Makoto Matsui, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	392 - Low Levels of Alpha-Synuclein in Peripheral Tissues are Related to Clinical Relapse in Relapsing-Remitting Multiple Sclerosis
11:30 AM - 05:30 PM	Abstract	393 - Impaired Structural Brain Connectome in Patients with Systemic Lupus Erythematosus and Multiple Sclerosis: A Graph Theory Study Paolo Preziosa
11:30 AM - 05:30 PM	Abstract	394 - Cerebrospinal Fluid IgA Levels Correlate with Disease Activity in Patients with Multiple Sclerosis; A Novel Finding Alexandra L. Tse, BS
11:30 AM - 05:30 PM	Abstract	395 - Laboratory Assessment Of Mitochondrial Dysfunction In Patients With Multiple Sclerosis Ahmed E. Mohamed, MD
11:30 AM - 05:30 PM	Abstract	396 - CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury Nicole Ziliotto
11:30 AM - 05:30 PM	Abstract	397 - Elevated LGI1-IgG CSF index predicts worse neurological outcome Anastasia Zekeridou, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	398 - Inhibition of FGFR1/2 decreases oligodendrocyte proliferation through ERK signaling in vitro Vinothkumar Rajendran
11:30 AM - 05:30 PM	Abstract	399 - Cerebrospinal Fluid S-Adenosyl Methionine Levels are Decreased in Multiple Sclerosis Patients Matthew A. mendelsohn, BA
11:30 AM - 05:30 PM	Abstract	400 - Physicochemical and Biological Characterization of both Copaxone and the European Follow-On Glatiramer Acetate Product
11:30 AM - 05:30 PM	Abstract	401 - An Hexameric Soluble Form the Pathogenic Protein from Human Endogenous Retroviral Type W Elements (pHERV-W-ENV) is Specifically Extracted from Demyelinating MS Lesions.
11:30 AM - 05:30 PM	Abstract	402 - Effects of Cladribine Tablets on CD4+ T-cell Subsets in the ORACLE-MS Study: Results from an Analysis of Lymphocyte Surface Markers Thomas Leist, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	403 - Relative Bioavailability of Monomethyl Fumarate after Administration of ALKS 8700 and Dimethyl Fumarate in Healthy Subjects Angela Wehr
11:30 AM - 05:30 PM	Abstract	404 - Immune-related microRNAs are differentially regulated in the cerebrospinal fluid of Multiple Sclerosis patients according to disease activity and their profile mirrors neuroinfectious diseases Vincent Van Pesch, MD, PhD
11:30 AM - 05:30 PM	Abstract	405 - Effects of MS Donor-Derived Mesenchymal Stem Cell-Neural Progenitors (MSC-NP) on Microglial Polarization
11:30 AM - 05:30 PM	Abstract	406 - Immune-regulatory Role of Mucosal-associated Invariant T cells (MAIT) in MS: a Follow-up Study. Jorge D. Correale, MD
11:30 AM - 05:30 PM	Abstract	407 - The Search for the Missing Antibody Jessica Lin, MD
11:30 AM - 05:30 PM	Abstract	409 - The Impact of Hard Drug Abuse as Risk Factor Prognosis in the Clinical Evolution of Patients with Multiple Sclerosis Maria C. Curbelo
11:30 AM - 05:30 PM	Abstract	410 - Retinal Structure Reflects Clinical Disease Severity in Relapsing Remitting Multiple Sclerosis Patients Melody Gilroy, BS
11:30 AM - 05:30 PM	Abstract	411 - FTY720 promotes cellular pathways involved in myelination and anti-oxidant system in the brain cortex Mehdi Mirzaei
11:30 AM - 05:30 PM	Abstract	412 - Early disease stage of Multiple Sclerosis in Chilean patients: cognitive impairment is a key domain and does not relate to MRI measures Carlos Guevara Oliva, MD
11:30 AM - 05:30 PM	Abstract	413 - Establishment of Optimal Bioanalytical Parameters for Measuring Neurofilament Light Chain (Nf-L) in Multiple Sclerosis (MS) Subjects from Clinical Trial Cohorts. Akash Datwani, PhD
11:30 AM - 05:30 PM	Abstract	414 - Dimethyl Fumarate Treatment alters T Cell Metabolism in Multiple Sclerosis
11:30 AM - 05:30 PM	Abstract	415 - Insomnia And Disability Severity Among Multiple Sclerosis Patients In Saudi Arabia
11:30 AM - 05:30 PM	Abstract	416 - Association of cognitive impairment in Multiple Sclerosis with polysomnographic measurement of sleep disorders Nuala McNicholas, MBBS
11:30 AM - 05:30 PM	Abstract	417 - Evaluation of different fatigue scales in assessment of fatigue in patients with multiple sclerosis
11:30 AM - 05:30 PM	Abstract	418 - Depression in Low Income Population with Multiple Sclerosis Britany Klenofsky, MD
11:30 AM - 05:30 PM	Abstract	419 - Evaluation of a Spasticity Management Program for People with Multiple Sclerosis: Full-scale Study Protocol Lucinda L. Hugos, PT
11:30 AM - 05:30 PM	Abstract	420 - Impact of Ocrelizumab on Cognition in Patients at Increased Risk of Progressive Disease Ralph H. Benedict, PhD
11:30 AM - 05:30 PM	Abstract	421 - "Real world" experience of medical marijuana in symptomatic management of multiple sclerosis and transverse myelitis Tirisham Gyang, MD
11:30 AM - 05:30 PM	Abstract	422 - The Impact of Cervical Spinal Cord Atrophy on Quality of Life in Multiple Sclerosis Jonathan D. Zurawski, MD
11:30 AM - 05:30 PM	Abstract	423 - Anxiety and Diabetes Adversely Affect Cognition in Multiple Sclerosis Ruth-Ann Marrie, MD, PhD
11:30 AM - 05:30 PM	Abstract	424 - Let's raise the awareness of MS specialists concerning the frequency and impact of RLS in MS and consequently the life quality of patients with MS: Striking results of the 'RELOMS-T' Study Serhan Sevim
11:30 AM - 05:30 PM	Abstract	425 - Prevalence and Characteristics of the Pseudobulbar Affect in a Large Population of People with Multiple Sclerosis Kathryn Fitzgerald, PhD
11:30 AM - 05:30 PM	Abstract	426 - NA
11:30 AM - 05:30 PM	Abstract	427 - NA
11:30 AM - 05:30 PM	Abstract	428 - NA
11:30 AM - 05:30 PM	Abstract	429 - Clinical Meaning and Responsiveness of Skin Biopsy abnd Corneal Confocal Microscopy to Diabetic Neuropathy Progression A. Gordon Smith, MD, FAAN
11:30 AM - 05:30 PM	Abstract	430 - Schwann Cells Express Melanocortin Receptor Subtypes: Activation by ACTH 1-39 and Alpha-MSH Enhances Proliferation Robert P. Lisak, MD, FAAN
11:30 AM - 05:30 PM	Abstract	431 - Comparative Study for the Effects of Several Angiotensin Receptor Blockers on Immune-mediated Experimental Neuritis Toshiki Fujioka, MD
11:30 AM - 05:30 PM	Abstract	432 - Multi-parametric MRI of the Proximal and Distal Nerves of the Leg: Longitudinal Findings in Patients with Inherited Neuropathies Michael Pridmore, MA
11:30 AM - 05:30 PM	Abstract	433 - Electrophysiological Testing in Patients with Chronic Inflammatory Demyelinating Polyneuropathy Treated with Subcutaneous Immunoglobulin: The PATH Study Vera Bril, MD
11:30 AM - 05:30 PM	Abstract	434 - Mechanisms of autoantibodies to neurofascins in acquired demyelinating neuropathies Kristina R. Patterson, MD, PhD
11:30 AM - 05:30 PM	Abstract	435 - Patient Assisted Intervention for Neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS) Richard J. Barohn, MD, FAAN
11:30 AM - 05:30 PM	Abstract	436 - Differences between Acute-onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) in adult patients. Lucas Alessandro, Sr., MD
11:30 AM - 05:30 PM	Abstract	437 - CORRELATION BETWEEN NERVE ULTRASOUND AND EXCITABILITY PARAMETERS IN DIABETIC NEUROPATHY Adeniyi A. Borire, MD
11:30 AM - 05:30 PM	Abstract	438 - Peripheral neuropathy in wild type transthyretin amyloidosis. Fernanda Wajnsztajn, MD
11:30 AM - 05:30 PM	Abstract	439 - Recovery of Sensory Modalities after Peripheral Nerve Lesions at Forearm Level Associated with Mechanoreceptor and Sensory Nerve Fiber Function Christian Krarup, MD, DMSc, FRcP, FAAN
11:30 AM - 05:30 PM	Abstract	440 - Lumbosacral Radiculoplexopathy as the Initial Presentation of Lymphoma: A Report of Four Cases Robert J. Marquardt, DO
11:30 AM - 05:30 PM	Abstract	441 - The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy Ming-Jen Lee, MD, PhD
11:30 AM - 05:30 PM	Abstract	442 - Suprascapular Neuropathy: A review of 87 cases Anza B. Memon, MD, FAAN
11:30 AM - 05:30 PM	Abstract	443 - Neuralgic Amyotrophy in Children
11:30 AM - 05:30 PM	Abstract	445 - Abnormal spontaneous activity on electromyographic study of intrinsic foot muscles in patients with painful distal small fiber neuropathy. Prachi T. Parikh, MD
11:30 AM - 05:30 PM	Abstract	446 - Quality Improvement and Practice-Based Research in Peripheral Neuropathy Using the Electronic Medical Record Octavia B. Kincaid, MD
11:30 AM - 05:30 PM	Abstract	447 - Variability of fasting plasma glucose increased risks of painful diabetic peripheral neuropathy in patients with type 2 diabetes Ming-hong Chang, MD
11:30 AM - 05:30 PM	Abstract	448 - Utility of Genetic Testing to Identify Individuals Suspected of Having Hereditary ATTR (hATTR) Amyloidosis
11:30 AM - 05:30 PM	Abstract	449 - Demyelinating polyneuropathy with anti-myelin associated glycoprotein antibodies responsive to lenalidomide in combination with rituximab Tiffany H. Pike-Lee, MD
11:30 AM - 05:30 PM	Abstract	450 - Obinutuzumab (GAZYVA), a Potent Anti-B Cell Agent, in the Treatment of Rituximab- Unresponsive IgM Anti-Myelin-Associated-Glycoprotein (MAG)-Mediated-Neuropathy Goran Rakocevic, MD, FAAN
11:30 AM - 05:30 PM	Abstract	451 - Clinical and Genetic Features in X-Linked Charcot-Marie-Tooth Neuropathy (CMT-X) Patients from Turkey Fatma Yesim Parman, MD
11:30 AM - 05:30 PM	Abstract	452 - Guillain Barre Syndrome Following Stem Cell Transplant: A Single Institution Five -Year Retrospective Study Nicholas Metrus, MD
11:30 AM - 05:30 PM	Abstract	453 - Quantitative MRI of Nerve Pathology in Mouse Models of CMT1A and HNPP Isaac V. Manzanera, PhD
11:30 AM - 05:30 PM	Abstract	454 - Quantitative Ultrasound to Quantify Neurogenic Change in Hand Muscles in Ulnar and Median Neuropathy Maria G. Martucci, MD
11:30 AM - 05:30 PM	Abstract	455 - Clinical and Electrodiagnostic Findings in Neuropathy with Anti-Fibroblast Growth Factor Receptor 3 Antibodies Carmen R. Boessen
11:30 AM - 05:30 PM	Abstract	456 - A comparison of different laboratory and clinical findings in Small fiber neuropathy (SFN) Reyanna Massaquoi, MD
11:30 AM - 05:30 PM	Abstract	457 - Elevated Soluble ICAM in Patients with Peripheral Demyelination Adam Andrzey Niezgoda
11:30 AM - 05:30 PM	Abstract	458 - Worsening Chronic Inflammatory Demyelinating Polyneuropathy After Pembrolizumab Treatment of Metastatic Melanoma: A Case Report Shoichi Shimamoto, MD
11:30 AM - 05:30 PM	Abstract	459 - Expanding the Phenotype of SEPT9 Gene Mutations in Hereditary Neuralgic Amyotrophy: Slowly Progressive and Painless Bilateral Brachial Plexopathies Rocio Vazquez Do Campo, MD
11:30 AM - 05:30 PM	Abstract	460 - Phenotypic Spectrum of DYNC1H1 mutations in Brazilian Patients Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN
11:30 AM - 05:30 PM	Abstract	461 - Immune-Mediated Polyradiculopathy in a Patient with Melanoma Responsive to IVIG Christopher T. Doughty, MD
11:30 AM - 05:30 PM	Abstract	462 - Diagnostic Challenge of 12 cases of Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) Lise Phan, MD
11:30 AM - 05:30 PM	Abstract	463 - FGFR3 Antibodies in Neuropathy. What to do with them? Verena C. Samara, MD
11:30 AM - 05:30 PM	Abstract	464 - Clinical, Laboratory and Electrodiagnostic Features of Peripheral Neuropathy in Copper Deficiency and Copper Toxicity Jennifer Haynes, MD
11:30 AM - 05:30 PM	Abstract	465 - Differential Effects of Statins on Motor and Sensory Compared with Cortical Gene Expression Patterns Beth B. Hogans, MD, PhD
11:30 AM - 05:30 PM	Abstract	466 - Vascular factors to be correlated with diabetic polyneuropathy Kyong Jin Shin, MD
11:30 AM - 05:30 PM	Abstract	467 - EGR2 Mutations in Brazilian Patients - a Clinical, Electrophysiological and Genetic Profile Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN
11:30 AM - 05:30 PM	Abstract	468 - Behavioral lateralization and scototaxis unaltered by near future ocean acidification conditions in Poecilia latipinna (Sailfin Molly) Alex Remnitz
11:30 AM - 05:30 PM	Abstract	469 - Utilizing Drug Intervention to Inhibit Delayed Neuronal Death by Migrainous Spreading Depolarizations
11:30 AM - 05:30 PM	Abstract	470 - Exacerbated Alzheimer's Disease Pathology in Female Hippocampus and Frontal Cortex of Tg6799 Mice and Humans Relative to Males Sarah Hoffman
11:30 AM - 05:30 PM	Abstract	471 - Understanding the tPA Gap: the Role of Socioeconomics in Acute Stroke Care Latha Ganti, MD, MS, MBA, FACEP
11:30 AM - 05:30 PM	Abstract	472 - Higher Score on Preospital Los Angeles Motor Scale Predicts Likelihood of Mechanical Thrombectomy After Acute Ischemic Stroke. Latha Ganti, MD, MS, MBA, FACEP
12:00 PM - 12:05 PM	Discussion	P1.027
12:05 PM - 12:10 PM	Discussion	P1.028
12:10 PM - 12:15 PM	Discussion	P1.029
12:15 PM - 12:20 PM	Discussion	P1.030
12:20 PM - 12:25 PM	Discussion	P1.031
12:25 PM - 12:30 PM	Discussion	P1.032
12:30 PM - 12:35 PM	Discussion	P1.033
12:35 PM - 12:40 PM	Discussion	P1.034
12:40 PM - 12:45 PM	Discussion	P1.035
12:45 PM - 12:50 PM	Discussion	P1.036
04:00 PM - 05:30 PM	Discussion	Poster Author Standby Time

Faculty Disclosures
Nicole Gonzales, MD	The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Guy A. Rouleau, MD, PhD, FAAN	Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
	No disclosure on file
Hajime Yokota	No disclosure on file
Mohammed Qureshi, MD	Dr. Qureshi has nothing to disclose.
Tiffany H. Pike-Lee, MD	Dr. Pike-Lee has nothing to disclose.
Mausaminben Y. Hathidara, MD	Dr. Hathidara has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Abdulaziz M. Alghamdi, MBBS	No disclosure on file
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Lawrence P. Hudson, MD	No disclosure on file
Hsing Jung Lai, MD	No disclosure on file
Nagayama Shigemi, MD, PhD	No disclosure on file
Yan Hou, PhD, MB	Dr. Hou has nothing to disclose.
Gozde Erdemir, MD	No disclosure on file
Andrew Russman, DO, FAAN	Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Mary A. Willis, MD, FAAN	Dr. Willis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb.
Carlos S. Medina	No disclosure on file
Annett Petersen, MD	No disclosure on file
Lene Rosendahl	No disclosure on file
Dena Williams, DO	Dr. Williams has nothing to disclose.
Richard L. Smith, MD	No disclosure on file
Bradley V. Vaughn, MD, FAAN	Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with AAN that is relevant to AAN interests or activities.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Suzanne D. DeBrosse, MD	No disclosure on file
Tekalign Burka, MD	Dr. Burka has nothing to disclose.
Alexander Arnold, MD	No disclosure on file
Sankeerth Challagundla, MD	Dr. Challagundla has nothing to disclose.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Nathan S. Farkas, MD	No disclosure on file
Nitish Kumar, MD	Dr. Kumar has nothing to disclose.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Elinor Ben-Menachem, MD, FAAN	Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Walter A. Kukull, PhD, FAAN	The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Alexandru C. Barboi, MD	Dr. Barboi has nothing to disclose.
Ann C. McKee, MD	Dr. McKee has nothing to disclose.
Peter J. Dyck, MD, FAAN	Dr. Dyck has nothing to disclose.
Joseph I. Sirven, MD, FAAN	Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Elizabeth M. Berry-Kravis, MD, PhD	The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Salvatore DiMauro, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Jerzy Kamienowski	No disclosure on file
Sishir Mannava, MD	Dr. Mannava has nothing to disclose.
Guilherme S. Torezani, MD	Dr. Torezani has nothing to disclose.
Margi B. Patel, MD	No disclosure on file
Andres De Leon, MD	Dr. De Leon Benedetti has nothing to disclose.
Nazeem Arsalan, MD	No disclosure on file
Edward M. Manno, MD, FAAN	No disclosure on file
J. R. Singleton, MD	Dr. Singleton has received research support from NIH.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Marcondes C. Franca, Jr., MD	Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Carolina A. Rush, MD	Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi .
Billie Durn	No disclosure on file
Sai Sripada R. Koneru, Sr., MD	No disclosure on file
Fabiola De Marchi	Fabiola De Marchi has nothing to disclose.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
A. Gordon Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Jeffrey W. Clark, DO	Dr. Clark has nothing to disclose.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Jose Marin	No disclosure on file
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Isaac V. Manzanera, PhD	No disclosure on file
Tobias Loddenkemper, MD, FAAN	No disclosure on file
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Rosamund A. Hill, FRACP	No disclosure on file
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Helene Zephir	Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Yann Hyvert, PhD	Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Gauruv Bose, MD	Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Bose has received research support from Multiple Sclerosis Society of Canada.
Christopher Richards	No disclosure on file
Piotr Bzdyra, MD	No disclosure on file
Behnaz Jarrahi, PhD	No disclosure on file
Micaela Nannery	No disclosure on file
Manya Prasad, MD	Manya Prasad has nothing to disclose.
Kledisa Shemsi	Dr. Shemsi has nothing to disclose.
Olaf Stuve, MD, PhD, FAAN	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Seraj O. Makkawi, MBBS, FRCPC, FAAN	Dr. Makkawi has nothing to disclose.
Ferid I. Domi, Jr., MD	Dr. Domi has nothing to disclose.
Barbara F. Diniz, MD	No disclosure on file
Tina Liu, MD	Dr. Liu has nothing to disclose.
Fernando Castilho Pelloso	No disclosure on file
Risa Isonaka	Risa Isonaka has nothing to disclose.
Nicholas Crump, MD	No disclosure on file
Viktoria Papp	No disclosure on file
Jill S. Napierala, PhD	Dr. Napierala has nothing to disclose.
Ryan C. Winger, PhD	No disclosure on file
Sean Kennedy	No disclosure on file
Lan Jiang	No disclosure on file
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Jorge C. Kattah, MD, FAAN	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Fatemeh Hajighasemi, MD	No disclosure on file
Marcia Olandoski	No disclosure on file
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Robert T. Naismith, MD, FAAN	Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. Dr. Johnson has stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Carlos Perdomo	No disclosure on file
Eduardo Hummelgen, MD	No disclosure on file
Anna I. Myburgh	No disclosure on file
Marianna Manfrini	No disclosure on file
Amita Sehgal, PhD	No disclosure on file
Raquel Portillo Rivero	No disclosure on file
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Ellen Bubrick, MD	Dr. Bubrick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Thomas Brannagan III, MD, FAAN	Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Marc Debouverie, MD	Dr. Debouverie has nothing to disclose.
Venkatraman Thulasi, MD	Dr. Thulasi has nothing to disclose.
Vinicius Oliveira Rocha Rodrigues	No disclosure on file
Angela Wehr	No disclosure on file
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Edlira Shemsi, MD	Dr. Shemsi has nothing to disclose.
Nishita Singh, Sr., MD	The institution of Dr. Singh has received research support from Brain Canada.
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Thomas Grüter	Thomas Grüter has nothing to disclose.
Sherita Chapman, MD	Dr. Chapman has received personal compensation in the range of $100,000-$499,999 for serving as a Stroke Section Chief with VA Medical Center.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Denise F. Chen	Ms. Chen has nothing to disclose.
Monika Manchanda, MD	Dr. Manchanda has nothing to disclose.
Philippe Gailloud, MD	Dr. Gailloud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerenovus. Dr. Gailloud has received stock or an ownership interest from ArtVentive. The institution of Dr. Gailloud has received research support from Siemens Medical.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.
James R. Lupski, MD, PhD	Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Genetics Center.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Steven C. Yang, DO	Dr. Yang has nothing to disclose.
Emily J. Hill, MD	Dr. Hill has nothing to disclose.
Xuya Huang, MBBS, PhD	No disclosure on file
Adriana Carra	No disclosure on file
Mary Clare McKenna, MB BCh BAO PhD	Dr. McKenna has nothing to disclose.
Shafaq Mansoor, MD	Dr. Mansoor has nothing to disclose.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Timothy Kleinig, MD, PhD	Dr. Kleinig has nothing to disclose.
Isaac Molinero, MD	Dr. Molinero has nothing to disclose.
Hyeyoung Seol, MD	Dr. Seol has nothing to disclose.
Ruthvik Malladi	No disclosure on file
Leila Cohen	Leila Cohen has nothing to disclose.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Mohamad A. Mikati, MD	No disclosure on file
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Bruce H. Cohen, MD, FAAN	Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abliva/NeuroVive/Pharming. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis/Zogenix/USB. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision BioSciences . Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Pretzel. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth Bio. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Allergan. The institution of Dr. Cohen has received research support from Stealth Biotherapeutics. The institution of Dr. Cohen has received research support from BioElectron Technologies/PTC. The institution of Dr. Cohen has received research support from Astellas/MitoBridge. The institution of Dr. Cohen has received research support from Reneo Pharmaceuticals. The institution of Dr. Cohen has received research support from Abliva/Pharming. The institution of Dr. Cohen has received research support from Tisento. Dr. Cohen has received publishing royalties from a publication relating to health care. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with US DOJ/HHS; DVIC. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a CPT Advisor with AAN. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Foundation that is relevant to AAN interests or activities.
Ralf Baron, MD	No disclosure on file
Nicte Mejia, MD, MPH, FAAN	Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Jacob Pellinen, MD	The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science. The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
Kenneth C. Sassower, MD	No disclosure on file
Clarice Zhou, BS	No disclosure on file
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jed Black, MD	Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
John Legge, MD	No disclosure on file
Reyanna Massaquoi, MD	No disclosure on file
Allison Kiernan	No disclosure on file
J. Theodore Phillips, MD, PhD, FAAN	No disclosure on file
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
April Ruby	April Ruby has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ProJenX, Inc.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Jayanthi Mani, MD	No disclosure on file
Dheeraj Kalladka, MD	No disclosure on file
Gabriela Gilmour, MD	Dr. Gilmour has nothing to disclose.
Sara Mariotto, MD, PhD	Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from ��ɫ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Rujuta B. Wilson, MD	Dr. Wilson has nothing to disclose.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Eric Goldstein, MD	Dr. Goldstein has nothing to disclose.
Tanya Bredesen, NP	No disclosure on file
Makoto Hara, MD	Dr. Hara has nothing to disclose.
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Tanya H. Butt, MPH	No disclosure on file
Amanda Sandoval Karamian, MD	The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
Kimberly Goodspeed, MD	The institution of Dr. Goodspeed has received research support from Neurogene, Inc.
Dominic A. Hovsepian, MD	No disclosure on file
Andrew Christiana, MD	Dr. Christiana has nothing to disclose.
Simon Beshara, MD, PhD	No disclosure on file
Münife Neyal	No disclosure on file
Brenda F. Baker	No disclosure on file
Julia E. Thompson, MD	No disclosure on file
Deniz Tuncel	No disclosure on file
Anusha Boyanpally, MBBS	No disclosure on file
Fan Wu, PhD	No disclosure on file
Edgar A. Rios Piedra	No disclosure on file
Mateusz Makuch	No disclosure on file
Brian Litt, MD	Dr. Litt has received personal compensation in the range of $0-$499 for serving as a Consultant for Beacon Neurosystems. Dr. Litt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG. Dr. Litt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Litt has stock in Orph AI. Dr. Litt has stock in Hyperfine. Dr. Litt has stock in Detect. Dr. Litt has stock in Butterfly. Dr. Litt has stock in Identifeye. Dr. Litt has stock in Protein Evolution. The institution of Dr. Litt has received research support from Mirowski Foundation. The institution of Dr. Litt has received research support from Jonathan and Bonnie Rothberg. The institution of Dr. Litt has received research support from Neil and Barbara Smit. Dr. Litt has received intellectual property interests from a discovery or technology relating to health care.
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Kathryn Giles	Kathryn Giles has stock in Synderdisc. The institution of Kathryn Giles has received research support from Biogen.
Kanika Sharma, MD	Dr. Sharma has nothing to disclose.
Ikreet Cheema, MD	Dr. Cheema has nothing to disclose.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Elliott Salamon, DO	No disclosure on file
Sailaja Golla, MD	Dr. Golla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognoa .
Martha L. Cruz, MD	No disclosure on file
Michael F. Weston, MD	No disclosure on file
Michael Gallagher, DO	No disclosure on file
Eric Nagele, DO	Dr. Nagele has nothing to disclose.
Dorsey Paul, PA	No disclosure on file
Thomas C. Ferree, PhD	No disclosure on file
Wyatt P. Bensken	No disclosure on file
Andrew Murchison	No disclosure on file
Kristen Malloy	No disclosure on file
Saeed Ansari, MD	Dr. Ansari has nothing to disclose.
Himanshu Gupta, MD	Dr. Gupta has nothing to disclose.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Ernest R. Somerville, FRACP	No disclosure on file
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Kon Chu	Kon Chu has nothing to disclose.
Braydon Dymm, MD	Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AvoMD. Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glass Health.
Alejandro Gonzalez Aquines, Sr.	Mr. Gonzalez Aquines has nothing to disclose.
Elizabeth Spurgeon, MD	Dr. Spurgeon has nothing to disclose.
Marek Napierala, PhD	No disclosure on file
Janbernd Kirschner	No disclosure on file
Kelsey Riggs, MD	No disclosure on file
Devon I. Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Richard H. Haas, MD	Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SPARC. Dr. Haas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms. Dr. Haas has stock in Various Companies Stock Trading. The institution of Dr. Haas has received research support from NIH North American Mitochondrial Disease Consortium. The institution of Dr. Haas has received research support from Reneo Pharma. The institution of Dr. Haas has received research support from Astellas Pharma. The institution of Dr. Haas has received research support from Acadia Pharma. The institution of Dr. Haas has received research support from Taysha Gene Therapies. The institution of Dr. Haas has received research support from Tisento Pharma.
Jin J. Luo, MD, PhD, FAAN	Dr. Luo has nothing to disclose.
Olanike A. Odeniyi, MD	No disclosure on file
Ilana Lasner, DO	No disclosure on file
Julien Cavanagh, MD	Dr. Cavanagh has nothing to disclose.
Prateeka Koul, MD	Dr. Koul has nothing to disclose.
Mona Al Banna, MB BCh BAO	Dr. Al Banna has nothing to disclose.
Elaine Shi	No disclosure on file
Alessandro Burlina, MD	No disclosure on file
Peter E. Davis, MD	No disclosure on file
Rui Li	Mr. Li has nothing to disclose.
Jean Khoury, MD	Dr. Khoury has nothing to disclose.
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Stephanie Barnes, MBBS	No disclosure on file
Luca Giancardo	Luca Giancardo has received personal compensation for serving as an employee of AWS. Luca Giancardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rutgers University. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care.
Melanie J. von Schimmelmann	No disclosure on file
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Geoffrey K. Herkes, MBBS, PhD, FRACP	The institution of Dr. Herkes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Herkes has received personal compensation in the range of $5,000-$9,999 for serving as a Chair of Advisory Committee of Medicines with Therapeutic Goods Admin.
Jihene B. Sassi	Ms. Sassi has nothing to disclose.
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Jordan Broman-Fulks, MD	No disclosure on file
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Francine M. Testa, MD	No disclosure on file
Pritikanta Paul, MD	The institution of Dr. Paul has received research support from ZS Associates.
Yuri S. Macedo, MD	No disclosure on file
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Bryan J. Neth, MD, PhD	Dr. Neth has nothing to disclose.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Michael Jensen	No disclosure on file
S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN	Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Nathane B. Rezende, MD	Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Aztrazeneca. Dr. Rezende has received research support from ECTRIMS.
Joshua Santucci, MD	Dr. Santucci has nothing to disclose.
Glen A. Cook, Jr., MD, FAAN	Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Shyamal Mehta, MD, PhD, FAAN	Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Alejandra Duque Ramirez, MD	Dr. Duque Ramirez has nothing to disclose.
Richard A. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Pramod Chopade, MD	No disclosure on file
Xiaoyu Jiang	Xiaoyu Jiang has received personal compensation for serving as an employee of Sanofi.
Robert Chong, MD	No disclosure on file
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Heather Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Andrei Ivashynka, MD, PhD	Dr. Ivashynka has nothing to disclose.
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
Ulrich Bogdahn, MD	No disclosure on file
Samir Blel, MD	No disclosure on file
Marni Falk	No disclosure on file
Sarah M. Tisel, MD	No disclosure on file
Vinothkumar Rajendran	Mr. Rajendran has nothing to disclose.
Alexander P. Auchus, MD, FAAN	Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Fang Bai, MD	No disclosure on file
Swathy Chandrashekhar, MD	Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Basak Karakurum Goksel	No disclosure on file
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Christian Wigley	No disclosure on file
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Deborah H. Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Daniel H. Geschwind, MD, PhD	Dr. Geschwind has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ovid Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Falcon Computing. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier-Biological Psychiatry. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NYAS. Dr. Geschwind has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington& Burling LLP. Dr. Geschwind has stock in none related to talk. The institution of Dr. Geschwind has received research support from CurePSP. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from Rainwater Charitable Foundation. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from The Simons Foundation. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS/NIA. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NIH/NINDS. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from U of Virginia and NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from NIH/NHGRI. The institution of Dr. Geschwind has received research support from NIH/NIMH. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care.
Rajiv Patni, MD	No disclosure on file
Dharampreet Singh, MD	No disclosure on file
Julieta Rosales	Ms. Rosales has nothing to disclose.
Annabel K. Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Serhan Sevim	No disclosure on file
Shai N. Gozani	No disclosure on file
Colin Mitchell, PhD	No disclosure on file
Avi Gadoth, MD	Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care.
Alexandra Galati, MD	No disclosure on file
Matthew Sumicad	No disclosure on file
Matthew A. mendelsohn, BA	No disclosure on file
Anthony P. Geraci, MD, FAAN	Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Geraci has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Geraci has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion.
Carmen R. Boessen	No disclosure on file
Erez Nossek	No disclosure on file
Byron Gajewski	No disclosure on file
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Debra Shabas, MD	No disclosure on file
Norman Putzki, MD	No disclosure on file
Puja Mathur, MD	No disclosure on file
Megan Grosso	No disclosure on file
Joao Marcos C. Ferreira, Sr., MD	No disclosure on file
Pippa S. Loupe, PhD	No disclosure on file
Sigal Melamed-Gal	No disclosure on file
Federico Eberbach	No disclosure on file
Christin Nance, BA	No disclosure on file
Katherine Moretz, MD	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Rashi K. Krishnan, MD	No disclosure on file
Jaanai Babb	No disclosure on file
Melody Gilroy, BS	Ms. Gilroy has nothing to disclose.
Anjali Mishra	No disclosure on file
Erin Abner	No disclosure on file
Tushar Patil, MD, MBBS	No disclosure on file
Yi-Chung Lee, MD, FAAN	The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Partha S. Ghosh, MD, FAAN	Dr. Ghosh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ghosh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Muna Irfan, MD	Dr. Irfan has nothing to disclose.
Rahul H. Rahangdale, MD	Dr. Rahangdale has nothing to disclose.
Elahhe Afkhamnejad	No disclosure on file
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Sankara Sarma	No disclosure on file
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN	The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from CRANIA. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Tanenbaum Institute for Science in Sport. .
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Ingrid F. De Vasconcellos, MD	No disclosure on file
Neel Dixit, MD	Dr. Dixit has nothing to disclose.
Anna Pace, MD	Dr. Pace has received personal compensation in the range of $0-$499 for serving as a Conference speaker with ��ɫ��.
Harish Jayakumar, MD MRCP DM DNB FRCP FEBN PDF, FAAN	No disclosure on file
Jinny Min	No disclosure on file
Mary E. Finger	No disclosure on file
Alexandra L. Tse, BS	No disclosure on file
Dace Almane	No disclosure on file
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Martin McKeown, MD	No disclosure on file
Yi-Chu Liao, MD	Dr. Liao has nothing to disclose.
Marina Novikova, MD	Dr. Novikova has a non-compensated relationship as a Uncomprensated Board Member with Alzheimer's Association - Michigan chapter that is relevant to AAN interests or activities.
John M. Ravits, MD, FAAN	Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Sergio Martinez-Yelamos, MD	No disclosure on file
Jerome Hanna	No disclosure on file
Muhammad Rizwan Husain, MD	Dr. Husain has nothing to disclose.
Jessie Gibson, PhD, NP	No disclosure on file
Chaipat Chunharas	The institution of Mr. Chunharas has received research support from Program Management Unit for Human Resources & Institutional Development,Research and Innovation (PMU-B).
Mariko Hanson, MD	Ms. Hanson has nothing to disclose.
Akash Datwani, PhD	No disclosure on file
Hongquan Jiang, MD	No disclosure on file
Paolo Zamboni, MD	No disclosure on file
Jonathan C. Calkwood, MD	Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bio. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Calkwood has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Calkwood has received research support from Sanofi. The institution of Dr. Calkwood has received research support from Novartis. The institution of Dr. Calkwood has received research support from Astra Zenica. The institution of Dr. Calkwood has received research support from TG Therapeutics. Dr. Calkwood has a non-compensated relationship as a Board of Trustees with National MS Society that is relevant to AAN interests or activities.
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
Robert P. Lisak, MD, FAAN	Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Demetrius M. Maraganore, MD, FAAN	Dr. Maraganore has nothing to disclose.
Sandhya Kumar, MD	Dr. Kumar has nothing to disclose.
Iris Adelt	Iris Adelt has nothing to disclose.
David L. Ennist, PhD	No disclosure on file
Katja Kolpatzik	No disclosure on file
Arunmozhimaran Elavarasi, MD	Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH.
Robert Fishman, MD	Dr. Fishman has nothing to disclose.
Jessica Tate, MD	The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Terence J. O'Brien, MD	The institution of Prof. O'Brien has received research support from Eisai. The institution of Prof. O'Brien has received research support from UCB. The institution of Prof. O'Brien has received research support from BioGen. The institution of Prof. O'Brien has received research support from ES Theraputics. The institution of an immediate family member of Prof. O'Brien has received research support from Epidarex.
Dong Wook KIM	No disclosure on file
David F. Tang-Wai, MD, FRCPC	Dr. Tang-Wai has nothing to disclose.
J. Vincent Filoteo, PhD	No disclosure on file
Neelum T. Aggarwal, MD	Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with AtWHealth . Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with VCU Health.
Massimo Zeviani, MD, PhD	No disclosure on file
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
XIAOGUANG LI	No disclosure on file
Steven P. Ellis, Jr., MD	No disclosure on file
Veronique Latreille, PhD	No disclosure on file
Sarah Fiedler	Sarah Fiedler has nothing to disclose.
Mark Cort II, MD	No disclosure on file
Perry Shieh, MD, PhD, FAAN	Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Jeannette Lechner-Scott, MD, PhD, FRACP	The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Qing Liu, MD	No disclosure on file
Pierre Duquette, MD	The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Carmen Duran Herrera	No disclosure on file
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Miguel Angel Hernandez Perez	Miguel Angel Hernandez Perez has nothing to disclose.
Talal Aboud, MD	No disclosure on file
Aaron R. Switzer, MD	Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Company Limited.
Ehad Afreen, MD	Dr. Afreen has nothing to disclose.
Sheetal Hegde, MD	Dr. Hegde has nothing to disclose.
Andrea Falini	No disclosure on file
Melissa Mackenzie, MD	No disclosure on file
Patama Gomutbutra, MD	No disclosure on file
Muhammad Adeel Saleemi, MBBS	The institution of Dr. Saleemi has received research support from NIH.
Mariana Gandelman, PhD	Dr. Gandelman has received research support from NINDS.
Eseosa Ighodaro, MD, PhD	Dr. Ighodaro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Ighodaro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hilarity for Charity. The institution of Dr. Ighodaro has received research support from North Carolina Department of Health and Human Services.
P. Sarat Chandra	No disclosure on file
Daryl Wile, MD	No disclosure on file
Sumaiya Khondker, MD	No disclosure on file
David P. Randall, DO	Dr. Randall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst.
Virginia Skiba, MD	No disclosure on file
Jean C. Tsai, MD, PhD	No disclosure on file
Lise Phan, MD	No disclosure on file
Anna Barminova, MD	No disclosure on file
May A. Kim-Tenser, MD, MHA, FAHA	Dr. Kim-Tenser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi.
Sherif Elwan, MD, MBBCh	No disclosure on file
Pratheep Kumar S, MD	No disclosure on file
Margaret Yu, MD	No disclosure on file
Andrew J. Yantes, RN, NP, DNP	No disclosure on file
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
David G. Wright, MD	Dr. Wright has nothing to disclose.
Ali Bozorg, MD	Dr. Bozorg has received personal compensation for serving as an employee of UCB Biosciences. Dr. Bozorg has stock in UCB.
Wing Cheong Lee, MBBS	No disclosure on file
Adam J. Margolius, MD	Dr. Margolius has nothing to disclose.
Jeeyoung Oh, MD, PhD	Dr. Oh has nothing to disclose.
Priyanka Madaan	Priyanka Madaan has nothing to disclose.
Carlos Silva, MD	No disclosure on file
Joseph Gleeson, MD	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Charles M. Lourenco, MD, PhD	No disclosure on file
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Roy Alcalay, MD	Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Vijayshree Yadav, MD, FAAN	Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Christopher Calder, MD, PhD, FAAN	No disclosure on file
Violaine K. Harris, PhD	No disclosure on file
Cathy Goldstein, MD	No disclosure on file
Guillaume Mathey	Guillaume Mathey has nothing to disclose.
Pedro H. Macedo, Sr., MD	No disclosure on file
Malgorzata Miller, MD	The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial.
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
James D. Bowen, MD	Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Vicente Villanueva	Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Paladin. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical.
Dhairya Lakhani, MD	Dr. Lakhani has nothing to disclose.
Michelle L. Stockner	No disclosure on file
Ilaria Cani, MD	No disclosure on file
Adam Book, MD	No disclosure on file
Bruno C. Musch, MD	No disclosure on file
Tony Daniels	Tony Daniels has received personal compensation for serving as an employee of UCB. Tony Daniels has stock in UCB.
Jack Nguyen	No disclosure on file
Yicheng Lin, MD	Dr. Lin has nothing to disclose.
Madhukar Trivedi, MD, MBBS	No disclosure on file
Jamie P. Slettedahl, RN, NP, DNP	No disclosure on file
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Bruce Hermann, PhD	Bruce Hermann, PhD has nothing to disclose.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Masamichi Ikawa	No disclosure on file
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Ursula Bellugi	No disclosure on file
Anneke Van Der Walt, MD	Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Ming Ren, Sr., MD, PhD	No disclosure on file
P Lenin Sankar	No disclosure on file
Maria Thereza Drumond Gama, MD	No disclosure on file
Shuyu Wang, MBBS	No disclosure on file
Nassim Zanganeh, MS	No disclosure on file
Zaza Katsarava, MD	Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Sheffali Gulati, MD, FAMS, FIAP, FNASc, FIANs	Prof. Gulati has nothing to disclose.
Peng Soon Ng, MBBS	No disclosure on file
Fernando Maestu	Fernando Maestu has nothing to disclose.
Benjamin Emanuel, DO	Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Andrew Lin, MD	No disclosure on file
Nicole Ziliotto	No disclosure on file
James J. Gugger, Jr., MD, PharmD	Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Dana E. Greenia, RN, MS	No disclosure on file
Susan M. Linder	No disclosure on file
HyunJin Song	No disclosure on file
Adrian Rodriguez-Hernandez, MD	Dr. Rodriguez-Hernandez has nothing to disclose.
Kirsten Martin	No disclosure on file
Hannah Irvine, MD	Dr. Irvine has nothing to disclose.
Mehdi Mirzaei	No disclosure on file
Julia Vaamonde Gamo	No disclosure on file
Fernando Kok, MD	No disclosure on file
Violeta Diaz, MD	No disclosure on file
Bing-Wen Soong, MD, PhD, FAAN	No disclosure on file
Laura Simionescu, MD	Dr. Simionescu has received publishing royalties from a publication relating to health care.
Jonathan D. Zurawski, MD	The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Mario Ortega	No disclosure on file
Pauline A. Filipek, MD	No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Sebina Bulic, MD	Dr. Bulic has nothing to disclose.
Elizabeth M. Aradine, MD	No disclosure on file
Ahmed E. Mohamed, MD	No disclosure on file
Harneet Walia	No disclosure on file
Mark J. Fisher, MD	The institution of Dr. Fisher has received research support from NIH.
Giselle M. Petzinger, MD	No disclosure on file
Thiago C. Vale, MD	No disclosure on file
Jeffrey Binder, MD	No disclosure on file
Jerry Lin, BS	Mr. Lin has nothing to disclose.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
David Polston, MD	No disclosure on file
Makoto Yoneda	The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Pradeep K. Sahota, MD, FAAN	The institution of Dr. Sahota has received research support from VA Merit award.
Britany Klenofsky, MD	Dr. Klenofsky has nothing to disclose.
Aldo Mendez Ruiz, MD	No disclosure on file
Robert Yao	No disclosure on file
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Nathalie Derache	Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Mayowa Owolabi, MD, FAAN	Dr. Owolabi has nothing to disclose.
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Jeffrey M. Chavin, MD, FAAN	Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Amar Patel, MD	Dr. Patel has nothing to disclose.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Camila C. Piccinin, MD	Dr. Piccinin has nothing to disclose.
Ursula Boschert Shafaatian	Ursula Boschert has nothing to disclose.
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Cris S. Constantinescu, MD, PhD	Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Betsy N. Williams, PhD	Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Sharon Ash	No disclosure on file
Megan Hyland, MD	The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Veronica A. Bruno, MD	Dr. Bruno has nothing to disclose.
Faisal A. Alsallom, MD	Dr. Alsallom has nothing to disclose.
Pitcha Chompoopong, MD	Dr. Chompoopong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Chompoopong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Nataliya Pyatka, MD	Dr. Pyatka has nothing to disclose.
Yelena G. Pyatkevich, MD	Dr. Pyatkevich has received personal compensation for serving as an employee of Takeda. Dr. Pyatkevich has stock in Takeda.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Helen Petrovitch, MD	No disclosure on file
Karen S. Marder, MD, MPH, FAAN	Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Lauren B. Elman, MD	Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Björn Tackenberg, MD, FAAN	Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Caroline Papeix	Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Caroline Papeix has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS .
David Brassat, MD, PhD	No disclosure on file
Sami Bajwa, MD	No disclosure on file
Katerina Placek	No disclosure on file
Lucrecia Bandeo	Lucrecia Bandeo has nothing to disclose.
Daniel H. Lowenstein, MD	Dr. Lowenstein has received research support from NIH.
Laure Michel	No disclosure on file
Benjamin Turner, MD, MBBS	No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Murat Terzi, PhD	Dr. Terzi has nothing to disclose.
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Fernanda Wajnsztajn, MD	An immediate family member of Dr. Wajnsztajn has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Fatima Pantiu	No disclosure on file
Dongchao Shen	No disclosure on file
Helen Kim	No disclosure on file
Erin M. Okazaki, MD	Dr. Okazaki has nothing to disclose.
Nigar Dargah-Zada, MD	Dr. Dargah-Zada has nothing to disclose.
Alexandra Boubour	Ms. Boubour has received research support from The Fulbright Program.
Daphna Laifenfeld	No disclosure on file
Michael Tempest	No disclosure on file
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Mustapha A. Danesi, MD	No disclosure on file
Kathleen Poston, MD, FAAN	Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for alkermes. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for centessa. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Aninda Acharya, MD	Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Acharya has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Sandra D'Alfonso	No disclosure on file
Jocelyn Y. Cheng, MD, FAAN	Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
Lydiane Mondot	Lydiane Mondot has nothing to disclose.
Sonemany Salinthone, PhD	Dr. Salinthone has nothing to disclose.
Arun Krishnan, MD	Dr. Krishnan has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
James M. Noble, MD, FAAN	Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
Jonathan Ciron, MD	Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Brian Stephens, MD	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Eugenio Pucci	No disclosure on file
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
John-Ross Rizzo	No disclosure on file
Urvish K. Patel	Mr. Patel has nothing to disclose.
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Johannes Lorscheider	The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis.
José Ángel Motos García	No disclosure on file
Rina I. Falb, PhD	Dr. Falb has nothing to disclose.
Richard Leigh-Pemberton, MD	No disclosure on file
Alex Remnitz	No disclosure on file
Tan Guan Zhong	No disclosure on file
Kathleen Ryan	No disclosure on file
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Zheng Fan, MD	Dr. Fan has nothing to disclose.
Cristian Falup-Pecurariu, MD, PhD	Prof. Falup-Pecurariu has nothing to disclose.
Olivier Godefroy, MD, PhD, FAAN	Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ELSEVIER.
Maria I. Reyes-Mantilla, MD	Dr. Reyes-Mantilla has nothing to disclose.
Jonas Saute, MD	No disclosure on file
Neil R. Friedman, MD, MBChB	No disclosure on file
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Michael Pridmore, MA	No disclosure on file
Austin Larson	No disclosure on file
Lauren Strother	No disclosure on file
James Marriott, MD, MSc	Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis.
Maria Jesus Sobrido, MD, PhD	No disclosure on file
Jacek Losy, MD	No disclosure on file
Guy Schwartz, MD	Dr. Schwartz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Schwartz has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Aaronson Rappaport Feinstein & Deutsch, LLP.
Mohammad Fouladvand, MD	No disclosure on file
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Marcus W. Koch, MD, PhD	No disclosure on file
Han Wang, MD	Dr. Wang has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Mark Tarnopolsky, MD, PhD, FRCP	Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Sean D. Ruland, MD	Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Richard S. Young, MD, FAAN	Dr. Young has nothing to disclose.
Chih-Chao Yang, MD	No disclosure on file
Howard L. Geyer, MD, PhD	Dr. Geyer has received publishing royalties from a publication relating to health care.
Jennifer S. Hui, MD	Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Kelly Claire Simon, ScD	No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Sira Carrasco	No disclosure on file
Annie L. Hsieh, MD, PhD	An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Fred Sarfo	Fred Sarfo has nothing to disclose.
Emmanuel Mignot, MD, PhD	Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
Megan Amuan	No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Amanda C. Guidon, MD, MPH	An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to AAN interests or activities.
Carlos Guevara Oliva, MD	Dr. Guevara Oliva has nothing to disclose.
Deepmala Nandanwar, MD	Dr. Nandanwar has nothing to disclose.
Kang Zhang	No disclosure on file
Emma Wu	No disclosure on file
Neel Mehta, Neel Mehta	No disclosure on file
Ronald D. Chervin, MD, MS	No disclosure on file
Amy P. Perrin Ross, RN, APN MSN, CNRN	Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Alexion. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Franco Granella	Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono.
Mark Groves, MD	No disclosure on file
Letizia Mazzini	No disclosure on file
Mohan Kottapally, MD	Dr. Kottapally has nothing to disclose.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Michael Gurevich	No disclosure on file
David R. Cornblath, MD	Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Francois Grand-Maison, MD	Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Katya Rascovsky	No disclosure on file
Benjamin Zeskind	No disclosure on file
Nicholas Metrus, MD	Dr. Metrus has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for dotdash / Verywell Health.
Adeola Olowu, MD	No disclosure on file
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
M.Purificacion Salmeron Ato, MD	No disclosure on file
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Richard D. Dortch, PhD	Dr. Dortch has nothing to disclose.
Patrizia Sola	Patrizia Sola has nothing to disclose.
Ruta N. Yardi, MD	Dr. Yardi has nothing to disclose.
Maria S. Pacha	No disclosure on file
Milton Biagioni, MD	No disclosure on file
Jean-Marc Leger, MD, FAAN	No disclosure on file
Kenneth W. Sommerville, MD, FAAN	No disclosure on file
Vincent Van Pesch, MD, PhD	Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
W. O. Tobin, PhD, MBBCh, BAO, FAAN	Dr. Tobin has received publishing royalties from a publication relating to health care.
Zbigniew Stelmasiak, PhD	No disclosure on file
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Jose Luiz Pedroso, MD	Dr. Pedroso has nothing to disclose.
Sahil Gupta, MD	Dr. Gupta has nothing to disclose.
Michael W. Devereaux, MD, FAAN	Dr. Devereaux has received personal compensation for serving as an employee of DigiTrace part of Sleepmed. Dr. Devereaux has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kevin Trangle and Associates.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
David S. Goldstein, MD, PhD	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Chen Meng, MS	No disclosure on file
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Gustavo A. Patino, MD, PhD	Dr. Patino has nothing to disclose.
Aurelie Ruet	The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Caterina Garone	No disclosure on file
Brynn K. Dredla, MD	The institution of Dr. Dredla has received research support from NIH.
Muniza Sheikh	Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Nils Henninger, MD, PhD, FANA, FWSO	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Ivo N. Van Schaik, MD	No disclosure on file
Roberto Cantello	No disclosure on file
John C. Steele, MD	No disclosure on file
Paulus S. Rommer	Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Lara J. Cooke, MD	Dr. Cooke has nothing to disclose.
Leticia Tornes, MD, FAAN	Dr. Tornes has nothing to disclose.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Michael Yeung, MD	No disclosure on file
Leslie A. Morrison, MD, FAAN	No disclosure on file
Web Ross, MD	The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Csilla Rozsa, MD	No disclosure on file
Judd M. Jensen, MD	Dr. Jensen has nothing to disclose.
Samuel Goldman, MD, MPH	Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Littlepage Booth Leckman. The institution of Dr. Goldman has received research support from Michael J Fox Foundation. The institution of Dr. Goldman has received research support from US Department of Defense. The institution of Dr. Goldman has received research support from US Veterans Administration. The institution of Dr. Goldman has received research support from National Institutes of Health. The institution of Dr. Goldman has received research support from Health Resources and Services Administration. The institution of Dr. Goldman has received research support from American Academy of Pediatrics. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with University of California San Francisco. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with San Francisco Veterans Affairs Health Care System.
Louisa Kalsner, MD	No disclosure on file
Karin Woodman, MD	Dr. Woodman has nothing to disclose.
Shayna Zanker	No disclosure on file
Bruno Gran, MD, PhD	Dr. Gran has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Gran has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche UK. Dr. Gran has received publishing royalties from a publication relating to health care.
Ingemar S. Merkies, MD	No disclosure on file
Sanjay P. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Timothy M. Ellmore, PhD	Prof. Ellmore has nothing to disclose.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Zahra Nasr, MD	Dr. Nasr has nothing to disclose.
Winona W. Tse, MD	Dr. Tse has nothing to disclose.
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Donna L. Masterman, MD	Dr. Masterman has received personal compensation for serving as an employee of Prothena Biosciences . Dr. Masterman has stock in Prothena Biosciences.
Pablo Villoslada, MD, PhD, FAAN	Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Yong Won Cho, MD	No disclosure on file
Alessandra Lugaresi, MD	Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Edward Kim, MD	Dr. Kim has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Clement Pillainayagam, MD	No disclosure on file
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Laura Ragna, MD	No disclosure on file
Raymond Hupperts	No disclosure on file
Cavit Boz, MD	Dr. Boz has nothing to disclose.
Fariha Khalid, MD	No disclosure on file
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Matthew J. Mandel, MD	Dr. Mandel has received personal compensation for serving as an employee of EMD Serono.
Jian Han, PhD	No disclosure on file
Chike Ilorah, MD, MPH	No disclosure on file
Brandon Bond, MD	No disclosure on file
Russell P. Saneto, DO, PhD	Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REATA. Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. The institution of Dr. Saneto has received research support from NIH. The institution of Dr. Saneto has received research support from Zogenix. The institution of Dr. Saneto has received research support from GW Pharmaceuticals.
Zarazuela Zolkipli-Cunningham, MBChB	Dr. Zolkipli-Cunningham has nothing to disclose.
Gauri V. Pawar, MD, FAAN	Dr. Pawar has nothing to disclose.
Martin Rakusa, MD	No disclosure on file
Scott Vota, DO, FAAN	No disclosure on file
Mark L. Schomer, MD	No disclosure on file
Ting Wu, MD	No disclosure on file
Saul Reyes, MD	Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Christian Krarup, MD, DMSc, FRcP, FAAN	Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Hector R. Martinez, MD	Dr. Martinez has nothing to disclose.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Christen Kutz	No disclosure on file
Owen T. Owens, DO	Dr. Owens has nothing to disclose.
Randall Edgell, MD	Dr. Edgell has nothing to disclose.
Randi Hagerman	Randi Hagerman has received publishing royalties from a publication relating to health care.
Shareena A. Rahman, MD	Dr. Rahman has nothing to disclose.
Eric D. Marsh, MD, PhD	Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Sofia Gak, MD	No disclosure on file
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Edmond Teng, MD, PhD	Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Kristin Engelstad	No disclosure on file
Jerome Engel, Jr., MD, PhD, FAAN	Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebel. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Engel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Steven Barris. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cutler Law Firm. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care.
Richard Buchsbaum	No disclosure on file
Turgut Tatlisumak, MD	No disclosure on file
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Ming-Jen Lee, MD, PhD	No disclosure on file
Nicholas Schwab	The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Mark Cohen	Mark Cohen has nothing to disclose.
Teddy S. Youn, MD	Dr. Youn has nothing to disclose.
Andreas Schulte-Mecklenbeck	Andreas Schulte-Mecklenbeck has nothing to disclose.
Jacqueline Bernard, MD, FAAN	Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2ND MD. Dr. Bernard has received publishing royalties from a publication relating to health care.
Manuel S. Yepes, MD	Dr. Yepes has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Jonathan J. Halford, MD, FAAN	Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Halford has received stock or an ownership interest from Corticare. The institution of Dr. Halford has received research support from Takeda. The institution of Dr. Halford has received research support from SK Life Sciences. The institution of Dr. Halford has received research support from Biogen.
Arnfin Bergmann	Dr. Bergmann has nothing to disclose.
Frank L. Silver, MD	Dr. Silver has nothing to disclose.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Lisseth E. Burbano, MD, PhD	Ms. Burbano has received research support from The ��ɫ��.
Bhupendra O. Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Robert Hyde, PhD	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Maurice M. Ohayon, MD, PhD, DSc	The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
Katherine A. Riester, MPH	No disclosure on file
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Johan Van Hove	The institution of Johan Van Hove has received research support from CureARS, NIH, NKH Crusaders, Mito Foundation, Brodyn's Friends, Les Petits Bourdons, Maud & Vic NKH fund, Tucker's Titans, Mikaere foundation. Johan Van Hove has received intellectual property interests from a discovery or technology relating to health care.
Jukka Putaala	No disclosure on file
Lucy Fell	No disclosure on file
Cassio Henrique Taqu Martins	No disclosure on file
John Vest	John Vest has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. John Vest has received stock or an ownership interest from Alnylam Pharmaceuticals. John Vest has received intellectual property interests from a discovery or technology relating to health care.
Jorge Patiño	No disclosure on file
Omid Omidvar, MD	No disclosure on file
Maria Stefanidou, MD	Dr. Stefanidou has nothing to disclose.
Pablo B. Winckler, MD, PhD	Dr. Winckler has nothing to disclose.
Adam Andrzey Niezgoda	No disclosure on file
Amy Goldstein, MD	No disclosure on file
Myrna R. Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. An immediate family member of Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lamson Dugan & Murray LLP. The institution of an immediate family member of Dr. Rosenfeld has received research support from Sage Therapeutics. The institution of an immediate family member of Dr. Rosenfeld has received research support from Edmond J. Safra Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from La Caixa Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from Spanish Ministry of Health. The institution of an immediate family member of Dr. Rosenfeld has received research support from Department of Health, Government of Catalunya. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Simon Cronin, PhD	Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Veronica Ramirez, BSc	No disclosure on file
Mark Cohen, MD	No disclosure on file
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Sumit Parikh, MD	Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Bradford B. Worrall, MD, MSc, FAAN	The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Kerri Schoedel	No disclosure on file
David A. Marks, MD	Dr. Marks has nothing to disclose.
Arnold E. Eggers, MD	No disclosure on file
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Elijah Stommel, MD, FAAN	Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Christopher Lines	No disclosure on file
Faycal Hentati, MD	No disclosure on file
Virend Somers	Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Virend Somers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axome. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ApniMed. The institution of Virend Somers has received research support from National Institutes Health.
Slawomir Michalak, PhD	No disclosure on file
Pedro A. Kowacs, MD, FAAN	Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Majaz Moonis, MD, FAHA, FAAN	Dr. Moonis has nothing to disclose.
David G. Munoz, MD	No disclosure on file
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Steven Xian, MD	No disclosure on file
Dolores G. Moron	Dr. Moron has nothing to disclose.
Anusha Edara, MD	No disclosure on file
Naama Levy-Cooperman, PhD	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Sebastian Zaremba, MD	No disclosure on file
Vanessa Rizelio	No disclosure on file
Prachi Mehndiratta, MD	Dr. Mehndiratta has nothing to disclose.
Timothy Spelman	No disclosure on file
Yael Shiloh-Malawsky, MD	Dr. Shiloh-Malawsky has nothing to disclose.
Iftekhar Ahmed, MD, PC, FAAN	Dr. Ahmed has nothing to disclose.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Albert Saiz	Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Randy Robinson, PhD	No disclosure on file
Patricia L. Henegan	No disclosure on file
Joseph F. Carrera, MD	Dr. Carrera has nothing to disclose.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Kyong Jin Shin, MD	No disclosure on file
Njide Okubadejo, MD, FAAN	The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Lesley Schofield	No disclosure on file
Jiri G. Safar, MD	No disclosure on file
Aparna Vaddiparti, MD	Dr. Vaddiparti has nothing to disclose.
Gupta V. Harsh, MD	No disclosure on file
Leticia Alejandra Olguín-Ramírez, Jr.	No disclosure on file
Salman Mansoor	Mr. Mansoor has nothing to disclose.
Finn Sellebjerg, MD	Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Beth B. Hogans, MD, PhD	Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities.
Arun Chandok, MD	Dr. Chandok has nothing to disclose.
David L. Gordon, MD, FAHA, FANA, FAAN	Dr. Gordon has nothing to disclose.
Rajarshi Mazumder, MD, MPH	Dr. Mazumder has nothing to disclose.
Lawrence A. Zeidman, MD, FAAN	Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zeidman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Smith Blake Hill LLC. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
Nancy Arndt, NP	No disclosure on file
Stephen M. Newman, MD	Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme . Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Ryan J. Uitti, MD, FAAN	Dr. Uitti has nothing to disclose.
Ann D. Bass, MD	Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Jay Pathmanathan, MD, PhD	No disclosure on file
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Audrey Strongosky	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Shingo Konno, MD	Dr. Konno has nothing to disclose.
Magdalena Krbot Skoric	Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Hannah Mandle	No disclosure on file
Gloria Dalla Costa	No disclosure on file
Vijayaleskhmi Nair, MD	No disclosure on file
Mohammad J. Humayun, MD	Dr. Humayun has nothing to disclose.
Shervin Badihian, MD	Dr. Badihian has nothing to disclose.
Burkhard Becher, PhD	No disclosure on file
Maimoona Siddiqui, MBBS	No disclosure on file
Navid Manouchehri, MD	Navid Manouchehri has nothing to disclose.
Shoichi Shimamoto, MD	No disclosure on file
Elizabeth Ackermann, PhD	No disclosure on file
Charlotte Zerna	No disclosure on file
Piraye Serdaroglu, MD	No disclosure on file
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Max Hirshkowitz, PhD	No disclosure on file
Pradeep C. Bollu, MD	Dr. Bollu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Jafar Kafaie, MD, PhD, FAAN	Dr. Kafaie has nothing to disclose.
Masoud Majed, MD	Dr. Majed has nothing to disclose.
Jenny J. Feng, MD	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Sarah L. Matcha, NP	No disclosure on file
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS, MSc has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck Foundation. Angela Vincent, MBBS, MSc has received intellectual property interests from a discovery or technology relating to health care.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Anza B. Memon, MD, FAAN	Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Richard R. Darby, MD	Dr. Darby has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for criminal forensic cases. The institution of Dr. Darby has received research support from National Institutes of Health.
Abdulcemal Ozcan, MD	No disclosure on file
Mark Wu, MD, PhD	The institution of Dr. Wu has received research support from National Institutes of Health. The institution of Dr. Wu has received research support from Chan Zuckerberg Institute.
Christopher M. DeGiorgio, MD, FAAN	Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care.
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Nils Koch-Henriksen, MD	Dr. Koch-Henriksen has nothing to disclose.
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Josep Gamez, MD, PhD	The institution of Dr. Gamez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Gamez has received research support from Government of Spain (FIS FEDER).
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Maria C. Curbelo	No disclosure on file
Camilo Diaz-Cruz, MD	Dr. Diaz-Cruz has nothing to disclose.
Veeresh Kumar Nanjangud Shivamurthy, MBBS	No disclosure on file
Marcelo A. Kauffman, MD	No disclosure on file
Florian P. Thomas, MD, PhD, MA, FAAN	Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Makoto Matsui, MD, PhD, FAAN	No disclosure on file
E M. Bebin, MD, FAAN	Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Anna Khanna, MD	Dr. Khanna has nothing to disclose.
Laura Herbelin	No disclosure on file
John D. Fisk, PhD	The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care.
Cory J. Rice, MD	No disclosure on file
Sabrina Kuespert, PhD	No disclosure on file
Kristina R. Patterson, MD, PhD	Dr. Patterson has received personal compensation for serving as an employee of Amgen. Dr. Patterson has stock in Amgen.
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Abhay Kumar, MD	Dr. Kumar has nothing to disclose.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Weijun Jin, MD	Dr. Jin has nothing to disclose.
Marianna Spatola, MD, PhD, FAAN	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil.
Jennifer Haynes, MD	Dr. Haynes has nothing to disclose.
Nan Zhang	Nan Zhang has nothing to disclose.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Ayesha Naeem, MD, MBBS	No disclosure on file
Chun-Nan Hsu	No disclosure on file
Daniel G. Larriviere, MD, JD, FAAN	Dr. Larriviere has nothing to disclose.
Violaine Plante-Bordeneuve, MD	Dr. Plante-Bordeneuve has nothing to disclose.
Jau-Shin Lou, MD, PhD, FAAN	Dr. Lou has nothing to disclose.
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Donika K. Patel, DO	No disclosure on file
Shuchi Chaudhary, MD	Dr. Chaudhary has nothing to disclose.
Ingo Helbig, MD	The institution of Dr. Helbig has received research support from NIH, German Research Foundation, The Hartwell Foundation, International League Against Epilepsy. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Michael Cartwright, MD	Dr. Cartwright has received publishing royalties from a publication relating to health care.
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Divya Singhal, MD, FAAN	Dr. Singhal has nothing to disclose.
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Zsolt Illes, MD	No disclosure on file
Jette Lautrup Frederiksen Battisti, MD	No disclosure on file
Lars Bergmann, MD	Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Gulshan Yunisova, MD	Dr. Yunisova has nothing to disclose.
Noof M. Alamri, MBBS	No disclosure on file
Eric E. Smith, MD	Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Sharmila Suri Mohanram, MD	No disclosure on file
Tetsuo Ashizawa, MD, FAAN	An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Rana Karabudak, MD	Dr. Karabudak has nothing to disclose.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Marcia Waddington Cruz, MD	Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk.
Claudia Christina H. Kristensen, MD	No disclosure on file
Thomas Duginski, MD	No disclosure on file
Matthew Carraro	Dr. Carraro has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carraro has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Carraro has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Carraro has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Carraro has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Milena Pavlova, MD	Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pear Therapeutics. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Oakstone. The institution of Dr. Pavlova has received research support from Jazz. The institution of Dr. Pavlova has received research support from Vanda. The institution of Dr. Pavlova has received research support from Biomobie. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving as a Didactic article with Neurodiem.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Claudia Kawas, MD	The institution of Dr. Kawas has received research support from NIH.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Madhuri Behari, MD	No disclosure on file
Roberta Frigerio, MD	Dr. Frigerio has nothing to disclose.
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Jose-Rafael P. Zuzuarregui, MD	Dr. Zuzuarregui has nothing to disclose.
Naveen Addagatla, MD	No disclosure on file
Laura Jardim	No disclosure on file
Samuel J. Cohn, MD	No disclosure on file
Rita Mikhaylova, DO	No disclosure on file
Wei Xu	No disclosure on file
Maria Naylor, PhD	Dr. Naylor has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Naylor has stock in Biogen. Dr. Naylor has stock in Dyne Therapeutics.
Elison H. Sarapura Castro, MD	No disclosure on file
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Diana Ferraro, MD, PhD	Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Binding Site. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Adam Spira	No disclosure on file
I-Hweii A. Chen, MD, PhD, FAAN	The institution of Dr. Chen has received research support from Healey Center at Massachusetts General Hospital. The institution of Dr. Chen has received research support from General Hospital Corporation. The institution of Dr. Chen has received research support from Argenx.
Ramin Zand, MD	Dr. Zand has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for StrokeExperts. The institution of Dr. Zand has received research support from NIH. The institution of Dr. Zand has received research support from PCORI.
Jason P. Mendoza, PhD	Dr. Mendoza has received personal compensation for serving as an employee of Biogen. Dr. Mendoza has stock in Biogen.
Jacqueline A. Nicholas, MD	Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Frank Bittner, DO	Dr. Bittner has nothing to disclose.
Jeyaraj D. Pandian, MD, DM	Dr. Pandian has nothing to disclose.
Joerg Windsheimer, MD	No disclosure on file
John L. Berk	John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Aiden Haghikia, MD	Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Roberto Furlan	Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Tereza Gabelic	No disclosure on file
Penny D. McQueen	No disclosure on file
Erie Gonzalez Gutierrez, MD	Dr. Gonzalez Gutierrez has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Daniel R. Scoles, PhD, FAAN	The institution of Dr. Scoles has received research support from NIH.
Mary Jo Pugh, PhD, RN, FAAN	The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs.
Albert Hofman, MD, PhD	No disclosure on file
Edwin B. George, MD, PhD, FAAN	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alicia S. Parker, MD	An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Rosa Capozzo	No disclosure on file
Dolora R. Wisco, MD	Dr. Wisco has nothing to disclose.
Lauren E. Dunn, MD	Dr. Dunn has nothing to disclose.
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Rejo Cherian, MD	Dr. Cherian has nothing to disclose.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Claudia Sommer, MD, PhD	Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akigai. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kedrion. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Takeda. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Sommer has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Sommer has received research support from DFG. The institution of Dr. Sommer has received research support from BMBf.
Sujan Teegala S. Reddy, MD	Dr. Reddy has nothing to disclose.
David A. Bennett, MD	Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Leo McCluskey, MD	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Robert L. Carruthers, MD	Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Francisco Germiniani	No disclosure on file
Trisha R. Dickey, MD	Dr. Dickey has nothing to disclose.
Kalliopi Pitarokoili, MD	Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Abraham N. Lieberman, MD, FAAN	No disclosure on file
Lawrence M. Samkoff, MD, FAAN	Dr. Samkoff has nothing to disclose.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Gen Sobue, MD	Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
Lola C. Morgan, MD	Dr. Morgan has nothing to disclose.
Jayandra Himali	Jayandra Himali has nothing to disclose.
Bjorn Ambrosius	No disclosure on file
Fajun Wang, MD	Dr. Wang has nothing to disclose.
Lucinda L. Hugos, PT	Ms. Hugos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Evidera, Inc.. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Techspert.io Ltd.. Ms. Hugos has received research support from Portland VA. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received publishing royalties from a publication relating to health care.
Anthony R. Frattalone, MD	No disclosure on file
Aaron Ritter, MD	The institution of Dr. Ritter has received research support from NIH.
Maria G. Martucci, MD	Dr. Martucci has nothing to disclose.
Jeremias Motte, MD	The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Rama K. Maganti, MD, FAAN	No disclosure on file
Francesco Bibbiani, MD	Dr. Bibbiani has nothing to disclose.
Hyunmi Kim, MD	Dr. Kim has nothing to disclose.
Muhammad S. Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Ashkan Shoamanesh, MD	Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer AG. Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo . Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier Inc.. Dr. Shoamanesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurodiem.ca. The institution of Dr. Shoamanesh has received research support from Servier Canada Inc.. The institution of Dr. Shoamanesh has received research support from Daiichi Sankyo Ltd.. The institution of Dr. Shoamanesh has received research support from Bayer AG. The institution of Dr. Shoamanesh has received research support from Bristol-Myers Squibb. The institution of Dr. Shoamanesh has received research support from Octapharma Canada .
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Steven G. MacDonald, MD	No disclosure on file
Chaoran Ma	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.
Lucy Zhang, MD	Dr. Zhang has nothing to disclose.
Ahyuda Oh, PhD	Dr. Oh has nothing to disclose.
Gyujoon Hwang	No disclosure on file
Antara Finney-Stable	No disclosure on file
Daniel Moiseev	Daniel Moiseev has nothing to disclose.
Lisa K. Park	No disclosure on file
Teri R. Thomsen, MD	Dr. Thomsen has nothing to disclose.
Renzo Guerrini	Renzo Guerrini has nothing to disclose.
Heather Beckstrom	No disclosure on file
Christina Chrisman, MD	Dr. Chrisman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Chrisman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Chrisman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Chrisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson.
Fabio Adrian Barroso, MD	Fabio Adrian Barroso, MD has nothing to disclose.
Adeniyi A. Borire, MD	Dr. Borire has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS.
Wim L. Robberecht, MD, PhD	No disclosure on file
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Orlando G. Barsottini, MD, PhD	Dr. Barsottini has nothing to disclose.
Christopher Olm	No disclosure on file
Sarah J. Banks, PhD	No disclosure on file
Jillian Chan, MD	No disclosure on file
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.
Lucia Giannini	No disclosure on file
Noelia García Lax	No disclosure on file
Amy C. Lemen, MA, LCSW, C-ASWCM	No disclosure on file
Claire Roberts	No disclosure on file
Dennis Chuang, MD, PhD	No disclosure on file
Sarah Hoffman	No disclosure on file
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Alexa Beiser	Alexa Beiser has nothing to disclose.
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Vishal Jani, MD	Dr. Jani has nothing to disclose.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Omar M. Hussein, MD	No disclosure on file
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group chair with MSBase Foundation that is relevant to AAN interests or activities.
Manmeet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Alberto Cucca, MD	No disclosure on file
Stephen W. English, MD	Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Sherita Alai	No disclosure on file
Saif A. Bushnaq, MD	Dr. Bushnaq has nothing to disclose.
Sarah Tanveer, PhD, MA	The institution of Miss Tanveer has received research support from Laura and Arnold Foundation. The institution of Miss Tanveer has received research support from Food and Drug Administration.
Surabhi Kaul, MD	No disclosure on file
Camilo R. Gomez, MD, FAAN	Dr. Gomez has nothing to disclose.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Mariusz Sieminski, MD	No disclosure on file
Chaitanya Amrutkar, MD	No disclosure on file
Corey C. Ford, MD, PhD, FAAN	No disclosure on file
Sung-Tsang Hsieh, MD, PhD, FAAN	No disclosure on file
William J. Herring, MD, PhD	No disclosure on file
Wolfgang Grisold, MD, FAAN	No disclosure on file
Jose R. Romero, MD	The institution of Dr. Romero has received research support from NIH/NIA.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Marta Cordoba	No disclosure on file
Vivek Prabhakaran, MD	Dr. Prabhakaran has nothing to disclose.
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Manav Vyas, MD	The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Maria-Luiza Saraiva-Pereira	No disclosure on file
Leila Parand, MD	Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lily. Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Esai. Dr. Parand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peer view . Dr. Parand has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Speaker Bureau .
Gabriel R. De Freitas, MD, PhD	Dr. De Freitas has nothing to disclose.
Regine Buffels, MD	Dr. Buffels has nothing to disclose.
Robert D. Abbott, PhD	No disclosure on file
Lawrence Goldstein, PhD	No disclosure on file
Alberto D. Rivero, MD	No disclosure on file
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Olajide A. Williams, MD	Dr. Williams has nothing to disclose.
Rohan Arora, MD	The institution of Dr. Arora has received research support from Bayer.
Amy L. Phillips, PharmD	Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.
Laura J. Julian, PhD	No disclosure on file
Shannon Kolind, PhD, MSc, BSc	Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Anat Mirelman	Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Joy R. Esterlitz	No disclosure on file
Lisa Eunyoung Lee	Lisa Eunyoung Lee has nothing to disclose.
Victoria Smith	No disclosure on file
Pierre Grammond, MD	Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pendopharm. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Grammond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. The institution of Dr. Grammond has received research support from Roche.
Barbara S. Gordon-Kundu, MD	An immediate family member of Dr. Gordon-Kundu has received personal compensation for serving as an employee of Ceretype .
Orell Mielke, MD	No disclosure on file
Nir Giladi, MD, FAAN	Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
David Laplaud	No disclosure on file
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Elizabeth C. Neil, MD	No disclosure on file
Luis Querol, MD, PhD	Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX.
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Abhishek Lunagariya, MD	No disclosure on file
Kristin Salottolo, MPH	Ms. Salottolo has nothing to disclose.
Filippo Savoldi, MD	No disclosure on file
Victoria Levesque	No disclosure on file
Ihtesham A. Qureshi, MD	No disclosure on file
Richard F. Lewis, MD	No disclosure on file
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Xiomara Q. Rosales, MD	No disclosure on file
Ulf Kallweit	No disclosure on file
Fernando Scaglia, MD	Dr. Scaglia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
John L. Thompson, PhD	The institution of Dr. Thompson has received research support from NIH.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Francesc R. Graus, MD	Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Maurizio Leone, MD	Dr. Leone has nothing to disclose.
Scott Mintzer, MD	No disclosure on file
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Helena W. Lau	No disclosure on file
Sridhara S. Yaddanapudi, MD	Dr. Yaddanapudi has nothing to disclose.
Brian Appleby, MD	Dr. Appleby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Appleby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis. Dr. Appleby has received personal compensation in the range of $0-$499 for serving as a Consultant for Sangamo. The institution of Dr. Appleby has received research support from CJD Foundation. The institution of Dr. Appleby has received research support from Ionis. The institution of Dr. Appleby has received research support from Alector. The institution of Dr. Appleby has received research support from CDC. The institution of Dr. Appleby has received research support from NIH. Dr. Appleby has received publishing royalties from a publication relating to health care. Dr. Appleby has received publishing royalties from a publication relating to health care.
Giorgio Giannattasio	No disclosure on file
Carol H. Tham, MBBS, MRCP	Dr. Tham has nothing to disclose.
Uzoma B. Duru, MD	No disclosure on file
Dilip Kumar Jayaraman, MD	Dr. Jayaraman has nothing to disclose.
Fabian Model	No disclosure on file
Matthew Broderick, MD	Dr. Broderick has nothing to disclose.
Ellen Snyder, MD	Dr. Snyder has nothing to disclose.
David F. Cuellar Giraldo, Jr., MD	Dr. Cuellar Giraldo has nothing to disclose.
Christian Brandt, MD	Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Brandt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Dr. Brandt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Brandt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. The institution of Dr. Brandt has received research support from Rubin-Stiftung. Dr. Brandt has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Lara Jehi, MD	Dr. Jehi has nothing to disclose.
Angela N. Hays Shapshak, MD	The institution of Dr. Hays Shapshak has received research support from NIH/NINDS. Dr. Hays Shapshak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Department of Justice.
Miguel Wilken, MD	No disclosure on file
Sanford H. Auerbach, MD, FAAN	Dr. Auerbach has nothing to disclose.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Liying Cui, PhD	No disclosure on file
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Beatrice Pignolet	Beatrice Pignolet has nothing to disclose.
Justin B. Miller, PhD, ABPP/CN	No disclosure on file
Aubree Bruhnding, DO	Dr. Bruhnding has nothing to disclose.
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Jesus E. Pina-Garza, MD	Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Jose Manuel Rodriguez Garcia, MD	No disclosure on file
Wei Hu, MD, PhD	No disclosure on file
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Radu Tanasescu, MD, PhD, FAAN	Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Thiago Rezende	Mr. Rezende has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Mr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC. The institution of Mr. Rezende has received research support from FARA. The institution of Mr. Rezende has received research support from Fapesp.
Sophie Samuel, PharmD	No disclosure on file
Kamila Bond	No disclosure on file
Seong-il Oh	No disclosure on file
Markus Reindl, PhD	The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Chi-Chao Chao	Chi-Chao Chao has nothing to disclose.
Tyler E. Gaston, MD	Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Anna Grisold, MD	No disclosure on file
Gabriela Trifan, MD	Dr. Trifan has nothing to disclose.
Michael H. Pfeiffer, MD, PhD	No disclosure on file
Michael J. Polydefkis, MD, FAAN	Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Hector J. Villarreal, MD	No disclosure on file
Lynn Kataria, MD	Dr. Kataria has nothing to disclose.
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
John R. Pollard, MD	No disclosure on file
Shennan A. Weiss, MD	No disclosure on file
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Rohit Dhall, MD, FAAN	Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Qin Li Jiang, MD	No disclosure on file
Sean Taylor, MD	No disclosure on file
Terrie Livingston, PharmD	Ms. Livingston has received personal compensation for serving as an employee of Octave Bioscience. Ms. Livingston has received personal compensation for serving as an employee of EMD Serono. Ms. Livingston has stock in Biogen. Ms. Livingston has stock in Octave Bioscience.
Amy K. Guzik, MD, FAAN	Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Isabel Conceicao	Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Tyler Koehn, MD	Dr. Koehn has nothing to disclose.
Anthony T. Allen II, MD	No disclosure on file
Francesca Sangalli	No disclosure on file
Maria I. Leite, MD	The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.
Acary S. Oliveira, MD	No disclosure on file
Aliya Sarwar, MD	Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
Jayson D. Rodriguez, MD	No disclosure on file
Bart Van Wijmeersch, MD, PhD	Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Mei-Sheng Duh, MPH, ScD	No disclosure on file
Qi Li, MD, PhD	No disclosure on file
Alexis N. Simpkins, MD, PhD, MSCR, FAHA, FANA, FAAN	Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Neurological Disorders and Stroke Data Safety Monitoring Board. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. The institution of Dr. Simpkins has received research support from NIH/NIA. The institution of Dr. Simpkins has received research support from Bristol-Meyer Squibb Foundation. Dr. Simpkins has received publishing royalties from a publication relating to health care.
Massimiliano Copetti	No disclosure on file
Valentina Emmanuele, MD, PhD	Dr. Emmanuele has nothing to disclose.
Tim-Henrik Bruun, PhD	No disclosure on file
Reed Johnson	No disclosure on file
Helena Arino, MD, PhD	Dr. Arino has nothing to disclose.
John Winkelman, MD, PhD	John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. John Winkelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Azurity. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Disc Medicine. An immediate family member of John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noctrix. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Psychogenics. The institution of John Winkelman has received research support from American Regent. The institution of John Winkelman has received research support from Merck. John Winkelman has received publishing royalties from a publication relating to health care. John Winkelman has a non-compensated relationship as a Chair with International Restless Legs Syndrome Study Group that is relevant to AAN interests or activities. John Winkelman has a non-compensated relationship as a Member with Restless Legs Syndrome Foundation Scientific Medical Advisory Board that is relevant to AAN interests or activities.
Arturo Garay, MD	No disclosure on file
Addie Patterson, DO	Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
S H. Subramony, MBBS, FAAN	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex.
Egemen Idiman, MD	No disclosure on file
Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN	Dr. Uchoa Cavalcanti has nothing to disclose.
Helle Hvilsted Nielsen, MD, PhD	No disclosure on file
Pouya Khankhanian, MD	No disclosure on file
Kersten Sharrock	No disclosure on file
Robert J. Marquardt, DO	Dr. Marquardt has nothing to disclose.
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Courtney Wusthoff, MD, FAAN	Dr. Wusthoff has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ICON. Dr. Wusthoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Wusthoff has received research support from NIH. Dr. Wusthoff has received publishing royalties from a publication relating to health care.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Anthony Reder, MD	Dr. Reder has nothing to disclose.
Oluwadamilola O. Ojo, MD	Dr. Ojo has nothing to disclose.
Stefan Braune	Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Xuling Lin, MD	The institution of Dr. Lin has received research support from National Health Innovation Center.
Leslie E. Perry Grayson, MD	Dr. Perry Grayson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals . The institution of Dr. Perry Grayson has received research support from Department of Defense .
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Jessie Huisinga	No disclosure on file
Rocio Vazquez Do Campo, MD	Dr. Vazquez Do Campo has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with US Department of Health, vaccine compensation program.
Maureen Neary	No disclosure on file
Dinesh Kumar	Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Merrill Benson	No disclosure on file
Patricia A. Evans, MD, PhD, FAAP, FAAN	Dr. Evans has nothing to disclose.
Craig M. Powell, MD, PhD, FAAN	No disclosure on file
Omar Khan, MD, FAAN	Dr. Khan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Director of Epilepsy Center with Veterans Affairs. An immediate family member of Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Clinical Reviewer with FDA.
Vernon D. Rowe, MD, FAAN	No disclosure on file
Kathryn A. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Premkumar Nattanmai Chandrasekaran, MD	Dr. Nattanmai Chandrasekaran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma.
Christian Bien, MD	Dr. Bien has nothing to disclose.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Aman Deep, MD	Dr. Deep has nothing to disclose.
Francisco Javier Ricart	Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
Derek Cheng, MD	No disclosure on file
Maria E. Jimenez-Capdeville, PhD	Dr. Jimenez-Capdeville has nothing to disclose.
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Naveed Malek, MD	Dr. Malek has nothing to disclose.
Judith D. Steinberg, MD	No disclosure on file
Supreet Kaur, MD	Dr. Kaur has nothing to disclose.
Jessica Lin, MD	Dr. Lin has nothing to disclose.
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Nathaniel Bendahan, MD	No disclosure on file
Mohannad Assiri	Mohannad Assiri has nothing to disclose.
Keerthivaas Premkumar	No disclosure on file
Shanu Roemer	Shanu Roemer has nothing to disclose.
Brett Monia, PhD	No disclosure on file
Katherine Nearing, MD	Dr. Nearing has nothing to disclose.
John A. Kamholz, MD	Dr. Kamholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Kamholz has received research support from HDSA.
Lysa Boissé Lomax, MD	Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, Eisai, Sunovion. Dr. Boissé Lomax has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Correctional Service Canada. The institution of Dr. Boissé Lomax has received research support from UCB.
Angel P. Sempere, MD	Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Malik Adil, MBBS	No disclosure on file
Toshiki Fujioka, MD	Dr. Fujioka has nothing to disclose.
Teresa Coelho, MD	Dr. Coelho has nothing to disclose.
Jason Mathew, DO	Dr. Mathew has nothing to disclose.
Colin A. Ellis, MD	Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder.
Nicholas J. Everage	No disclosure on file
Dominique Low, MD	Dr. Low has nothing to disclose.
Damon P. Cardenas, PhD	No disclosure on file
Ayse Candayan	Ayse Candayan has nothing to disclose.
Thor Petersen	No disclosure on file
Rana Hanna AL-Shaikh, MD	Dr. Hanna AL-Shaikh has nothing to disclose.
Naresh Mullaguri, MD	Dr. Mullaguri has nothing to disclose.
Samden Lhatoo, MD	Dr. Lhatoo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova. The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
Maria Corrada, PhD	The institution of Dr. Corrada has received research support from NIH.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Matthias Kant	Matthias Kant has nothing to disclose.
Wataru Hagiwara	No disclosure on file
Francisco E. Gomez III, MD	No disclosure on file
Bashiruddin K. Ahmad, MD	No disclosure on file
Payam Moein, MD	No disclosure on file
Mehul Jhaveri	Mehul Jhaveri has received personal compensation for serving as an employee of Biogen. Mehul Jhaveri has received stock or an ownership interest from Biogen.
John A. Hunter	No disclosure on file
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Lori Mayer, RN, DNP, MSN, MSCN	Ms. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Feza Deymeer, MD	No disclosure on file
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Karen Black	No disclosure on file
Leonardo Almeida	No disclosure on file
Luke Whitmire, PhD	No disclosure on file
Craig Wakeford	No disclosure on file
Charlotte Kwok	No disclosure on file
Sandra Diaz Garcia, PhD	No disclosure on file
Adil Javed, MD, PhD	The institution of Dr. Javed has received research support from Genentech Roche .
Samuel Pfaff, MD	No disclosure on file
Pue Farooque, DO	No disclosure on file
Boyd M. Koffman, MD, PhD	Dr. Koffman has nothing to disclose.
Ambihai Sivalingam	No disclosure on file
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Hailong Cheng	No disclosure on file
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Davida Goltz, MD	No disclosure on file
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Katherine G. Iannuzzelli	No disclosure on file
Sanjeev V. Thomas, MD, FAAN	Dr. Thomas has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley India. The institution of Dr. Thomas has received research support from Government of India.
Christopher T. Doughty, MD	Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.
Sara Razmjou-Schwarz, MD	No disclosure on file
Brandi L. Vollmer, MPH	Ms. Vollmer has nothing to disclose.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Robert Hendricks	No disclosure on file
Leila Saadatpour, MD	Dr. Saadatpour has nothing to disclose.
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Janet Elgallab, MD	No disclosure on file
Sharan Paul, PhD	Dr. Paul has nothing to disclose.
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Scott M. Le, DO	No disclosure on file
Balasubramanian Samivel, MD	Dr. Samivel has nothing to disclose.
Sharmeen Hussaini, MBBS	No disclosure on file
Jason B. Richards, MD	The institution of Dr. Richards has received research support from Brown Physicians, Inc.
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Jiong Shi, MD, FAAN	Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Juebin Huang, MD, PhD	Dr. Huang has nothing to disclose.
Lila E. Sheikhi, MD	Dr. Sheikhi has nothing to disclose.
Herve Perron, PhD	Mr. Perron has received personal compensation for serving as an employee of Geneuro-Innovation. Mr. Perron has stock in GeNeuro. The institution of Mr. Perron has received research support from European Union (EU) HORIZON HEALTH Program.
Jan Leonard	No disclosure on file
Leenu Gupta, MBBS MD	No disclosure on file
Teresa Ayuso, MD	No disclosure on file
Bradley W. McEvoy	Bradley W. McEvoy has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Bradley W. McEvoy has received stock or an ownership interest from Acadia Pharmaceuticals.
Sarah Ganji, MD	No disclosure on file
Shahram Amina, MD	No disclosure on file
Vida Abedi	No disclosure on file
Antonio Anaya-Escamilla, MD	No disclosure on file
Steven hughes	No disclosure on file
David D. Adams	David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Egon Stenager, MD	No disclosure on file
Tanya Harlow, MD, FAAN	Dr. Harlow has nothing to disclose.
Melinda Magyari, MD	Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Esra Battaloglu	Esra Battaloglu has nothing to disclose.
Quang D. Vu, MD	No disclosure on file
Veronica P. Cipriani, MD, FAAN	Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Cipriani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Pharmaceuticals. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Cipriani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Cipriani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Vaccine Injury Compensation Program. Dr. Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Member of Board of Directors with Chicago MS Alliance.
Danny Samkutty, MD	Dr. Samkutty has nothing to disclose.
Mohammed Alqahtani	Mohammed Alqahtani has nothing to disclose.
Jeanna West-Miles, DO	No disclosure on file
Shailesh Male, MD	Dr. Male has nothing to disclose.
Deepa Dash, MD, DM	Dr. Dash has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Wilson Marques, Jr., MD	Dr. Marques has nothing to disclose.
Ajay Garg	Ajay Garg has nothing to disclose.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Ashish Kulhari, MD	No disclosure on file
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Jetter T. Robertson, DO	Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Preferred One . Dr. Robertson has stock in Doximity.
Usama Tariq, MBBS	Dr. Tariq has nothing to disclose.
Akiko Matsunaga, MD	AKIKO MATSUNAGA, MD has nothing to disclose.
Said R. Beydoun, MD, FAAN	Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Manoj Raghavan, MD, PhD	Dr. Raghavan has nothing to disclose.
Daniel Costello, MD	Dr. Costello has nothing to disclose.
Simon Borghs	No disclosure on file
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Amna Sohail, MD	Dr. Sohail has nothing to disclose.
Christian Cornelissen	No disclosure on file
Sean Selva	Sean Selva has nothing to disclose.
Paula E. Voinescu, MD	The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a PhD Opponent with University of Bergen, Norway. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Karina Milla-Neyra	No disclosure on file
Erick Figueroa-Ildefonso	No disclosure on file
Richard M. Dubinsky, MD, MPH, FAAN	Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Ming-hong Chang, MD	Dr. Chang has nothing to disclose.
Prachi T. Parikh, MD	Dr. Parikh has nothing to disclose.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow	The institution of Dr. Illanes-Manrique has received research support from GLOBAL BRAIN HEALTH INSTITUTE.
Damian Fiore	Damian Fiore has nothing to disclose.
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Mario R. Cornejo Olivas, MD	Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
Prateek Thatikunta, MD	No disclosure on file
Jang Yun	No disclosure on file
Paola Giunti	No disclosure on file
Linda A. Hershey, MD, PhD, FAAN	Dr. Hershey has received personal compensation for serving as an employee of ��ɫ��. Dr. Hershey has received personal compensation for serving as an employee of MedLink Neurology LLC. Dr. Hershey has received personal compensation for serving as an employee of American College of Physicians. Dr. Hershey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Hershey has stock in Diverse portfolio.
Michael P. Collins, MD	Dr. Collins has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Omar Saeed, MD	Dr. Saeed has nothing to disclose.
Ann Herman	Ann Herman has received personal compensation for serving as an employee of Genentech, Inc. Ann Herman has received stock or an ownership interest from F. Hoffman-La Roche Ltd.
Amrinder Singh, MD	No disclosure on file
Thor S. Stead	Mr. Stead has nothing to disclose.
Jack J. Chen, PharmD BCPS CGP	No disclosure on file
Xiang Gao, MD, PhD	Dr. Gao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nutrition Journal. The institution of Dr. Gao has received research support from NIH.
Mahesh M. Thakkar	No disclosure on file
Veena A. Nair, PhD	The institution of Dr. Nair has received research support from NIH.
Verena C. Samara, MD	An immediate family member of Dr. Samara has received personal compensation for serving as an employee of Supernus. The institution of Dr. Samara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Samara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Samara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Samara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. An immediate family member of Dr. Samara has stock in Supernus.
Eimer Maloney, MD	No disclosure on file
Gobind Singh, MBBS	No disclosure on file
Mohammad A. Kabir, MD	Dr. Kabir has received personal compensation for serving as an employee of Hamilton Physician Group. Dr. Kabir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened Inc. . Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Kabir has received personal compensation in the range of $0-$499 for serving as a Consultant for Livanova Inc. Dr. Kabir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Kabir has stock in ArgenX. Dr. Kabir has stock in Lilly. Dr. Kabir has stock in Pfizer.
Christopher Harp	Christopher Harp has received personal compensation for serving as an employee of Genentech. Christopher Harp has received stock or an ownership interest from Genentech, Inc..
Abby I. Metzler, MD	Dr. Metzler has nothing to disclose.
Thamilpavai Natarajan, MD	Dr. Natarajan has nothing to disclose.
Daniel Shalev	Mr. Shalev has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Hospice and Palliative Medicine. Mr. Shalev has received research support from Weill cornell. The institution of Mr. Shalev has received research support from National Institute of Aging. The institution of Mr. Shalev has received research support from National Institute of Mental health .
Shankar Iyer	No disclosure on file
Caitlin Bell	No disclosure on file
Irene L. Katzan, MD	Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Mohammad Ikram	The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Silke A. Cresswell, MD	No disclosure on file
Peter T. Nelson	Peter T. Nelson has nothing to disclose.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Ellen C. Wong, MD	Dr. Wong has received research support from National Institute on Aging.
Octavia B. Kincaid, MD	Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Group.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
Ranjithkumar Rajendran	Mr. Rajendran has nothing to disclose.
Nandakumar Nagaraja, MD	The institution of Dr. Nagaraja has received research support from 1 Florida Alzheimer's Disease Research Center. Dr. Nagaraja has received personal compensation in the range of $500-$4,999 for serving as a stroke outcome adjudicator for WHI study with Fred Hutchinson Cancer Research Center.
Jalyoung Joe, MD	Dr. Joe has nothing to disclose.
Frederic Heerinckx, PharmD	No disclosure on file
Mellissa Withers	No disclosure on file
Christina Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH Stroke Net. The institution of an immediate family member of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Bristol-Myers Squibb and BMS-Pfizer/Roche Diagnostics . An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Quynh Vo, MD	Dr. Vo has nothing to disclose.
Nuala McNicholas, MBBS	Dr. McNicholas has nothing to disclose.
Wojciech Kozubski	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��